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Toll-like Receptors (TLRs) are essential innate receptors which recognize conserved 
structures of pathogens, or danger signals released from damaged cells. Alterations of 
TLR responses might result in severe viral infections or a higher risk of cancer. 
Therefore, development of clinical assays to evaluate TLR functions could provide 
personalized information about susceptibility to these diseases. Since TLRs are 
differentially expressed on different subsets of human peripheral blood mononuclear 
cells (PBMCs), a multi-color flow cytometry-based assay was developed to detect TLR 
responses of individual cell types simultaneously. We observed that the magnitude of 
TLR responses largely varied between human subjects, but was highly reproducible 
over one month.  
To evaluate the potential role of differences in natural killer (NK) cell TLR response we 
studied the association of NK cell TLR function and TLR single nucleotide 
polymorphisms (SNPs) with susceptibility to recurrent herpes labialis (HL) and gastric 
cancer. Using our assay, impaired TLR3 response of NK cells was found in people with 
recurrent HL. In addition, we have identified enhanced levels of homozygous TLR3 
L412F SNP in people with recurrent HL, which results in lower surface expression and 
reduced NK cell response to poly(I:C).  
TLR1 I602S, another common SNP, has been reported to decrease TNF- responses of 
monocytes toward TLR2/1 agonist, Pam3CSK4 (Pam3Cys), stimulation. In our study, 
we found that TLR1 I602S homozygosity also contributes to impaired IFN-γ responses 
of NK cells and CD8+T cells. Although we did not observe an association of TLR2/1 
deficiency with recurrent HL, association of TLR1 I602S with risk for primary as well as 
metastatic gastric cancer was found in a cohort of 326 patients.  
To sum up, our results suggest that genetic polymorphisms of TLRs can impair TLR 
function of NK cells, which contribute to the increased susceptibility to HSV-1 diseases 
and gastric cancer. 
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Toll-like Rezeptoren (TLRs) sind essentielle angeborene Rezeptoren, die konservierte 
Strukturen von Krankheitserregern oder Gefahrsignale, die von beschädigten Zellen 
freigesetzt werden, erkennen können. Genetische Variationen in TLRs wie Einzel-
Nukleotid-Polymorphismus (SNP) können die Funktion von TLRs beeinträchtigen und 
erste Studien zeigen, dass dies zu einer erhöhten Anfälligkeit gegenüber 
Virusinfektionen oder  einem erhöhten Krebsrisiko führen kann. In dieser Studie haben 
wir einen Multicolor-Durchflußzytometrie-Test entwickelt, um die TLR-Funktionen in 
verschiedenen Subpopulationen unseparierter peripherer mononukleärer Blutzellen 
(PBMCs) simultan analysieren zu können. Wir konnten beobachten, dass das Ausmaß 
der TLR-Antworten zwischen den Probanden stark variierte, jedoch über einen Zeitraum 
von einem Monat gut reproduzierbar war. 
Zunächst untersuchten wir TLR Reaktionen bei Patienten mit rezidivierenden Herpes 
labilalis (HL). Im Vergleich zu asymptomatischen Personen war eine HL- Anamnese mit 
einer signifikant verminderten TLR3-IFN-γ-Antwort nach Stimulation mit poly(I:C) in NK 
Zellen assoziiert. Weitere molekulare Untersuchungen zeigten eine mögliche 
Beteiligung von TLR3 L412F SNP, welcher die oberflächliche TLR3 Expression und  die 
IFN-γ-Antworten in NK-Zellen reduzierte. Einige Studien zeigen, dassTLR1 I602S, ein 
weiterer sehr verbreiteter SNP, in der Lage ist die TNF--Antworten von Monozyten 
gegen den TLR2/1-Agonisten (Pam3Cys) zu verringern. In der hier vorliegenden Arbeit 
konnten wir zudem nachweisen,  dass TLR1 I602S SNP auch die Funktion von NK-
Zellen und CD8+ T-Zellen beeinträchtigt. Wir konnten keine Assoziation zwischen 
TLR2/1-Defizienz und reaktivierendem HL feststellen. Jedoch  konnten wir an einer 
großen Kohorte von über 326 Patienten zeigen, dass der TLR1 SNP sowohl ein 
Risikofaktor für Magenkarzinomentstehung als auch für die Metastasierung ist. 
Zusammenfassend weisen unsere Ergebnisse darauf hin, dass genetische 
Polymorphismen von TLRs die Funktion von NK-Zellen beeinträchtigen und zu einer 
erhöhten Anfälligkeit für HSV-1 Erkrankung und Magenkarzinom führen können.   






TLR:   Toll-like receptor 
HSV:   Herpes simplex virus 
HSE:   Herpes simplex encephalitis 
HL:   Herpes labialis  
PBMC:   Peripheral blood mononuclear cell 
NK:   Natural killer cell 
mDC:   Myeloid dendritic cell 
pDC:   Plasmacytoid dendritic cell 
APC:   Antigen presenting cell 
rhIL-12:   Recombinant human interleukin-12 
Pam3Cys:   Pam3CSK4 
BFA: Brefeldin-A 
TNF-α:   Tumor necrosis factor- α 
IFN-γ:   Interferon- γ 
MFI:   Mean florescence intensity  
SNP:   Single nucleotide polymorphism 
APOE:   Apolipoprotein E 
NF-κB:   Nuclear factor- κB 





1.1 Overview of Toll-like receptors 
Toll-like receptors (TLRs) are important innate immune receptors that recognize 
conserved features of microbes, or referred to as pathogen-associated molecular 
patterns (PAMPs). TLRs bind to PAMPs through solenoid ectodomains, which contain 
leucin-rich repeats; and exert inflammatory responses via pathways derived from the 
intracellular Toll-Interleukin-1 receptor (TIR) domain [1,2]. TLRs were named for their 
similarity to Toll, a receptor originally involved in embryonic development of the fruit fly 
Drosophila melanogaster discovered in 1985 by the German scientist Christiane 
Nüsslein-Volhard. In 1996, Jules A. Hoffmann and colleges further showed the 
importance of Toll in combating fungal infection in fruit flies [3]. Human TLRs were 
subsequently identified and shown to be involved in sensing specific structures of 
microbial origin and even endogenous danger signals (reviewed in [4]). 
 
1.1.1 Toll-like receptors and viral infections 
In humans, there are TLR1-10 in the TLR family. The activation of TLR during viral 
infection is essential for the induction of dendritic cell (DC) maturation, the production of 
interferons, and the initiation of the adaptive immune system [5]. 
 
1.1.1.1 TLR 1, 2, 4, 6 
TLR 2 forms heterodimers with TLR1 or TLR6. Triacylated and diacylated lipoproteins, 
which are common gram-positive cell wall components, are ligands for TLR2/1 and 
TLR2/6. However, viral proteins of Herpes simplex virus -1, -2 (HSV-1, HSV-2), and 
Cytomegalovirus (CMV) have also been reported to be recognized by TLR2 [6,7]. 
Similarly, TLR4 is mainly activated by LPS, the component of the outer membrane of 
gram-negative bacteria, but it is also activated by the fusion protein of respiratory 





1.1.1.2 TLR 3, 7, 8, 9 
TLR3, 7, 8 and 9 are specialized in the recognition of viral nucleic acids. These 
receptors reside in the endosome. TLR3 can be activated by double-stranded RNA 
(dsRNA) which is often produced during viral replication; TLR7 and 8 are stimulated by 
single-stranded RNA (ssRNA); and TLR9 is responsible for recognizing the 
nonmethylated CpG nucleotides in DNA viruses. For all TLR signaling except TLR3, the 
adaptor Myeloid differentiation primary response protein 88 (MyD88) is important for the 
activation of NF-kB pathways and thus the production of proinflammatory cytokines. 
TIR-domain-containing adapter-inducing interferon-β (TRIF), on the other hand, is 
involved in TLR3- and TLR4- mediated MyD88-independent pathways, and is essential 
for the induction of both NF-kB and type I interferon signaling [9].  
 
1.1.2 Toll-like receptors and cancer 
TLRs play several roles in carcinogenesis. For example, engagement of TLR2/1 
complex significantly increases the anti-tumor activity of CD8T cells [10]. TLRs can also 
recognize endogenous signals released from damaged or dying tumor cells, thus 
breaking down tumor-induced immune tolerance [11]. Therefore, hypofunction of TLRs 
may increase risks for cancer. Furthermore, polymorphism in a promoter sequence of 
TLR2 and a TLR4 variant allele have been reported to be involved in Helicobacter pylori 
(H. pylori)-associated gastric cancer [12,13]. Polymorphism in the TLR10-TLR1-TLR6 
gene cluster, on the other hand, is associated with an increased risk for prostate cancer 
[14]. 
 
1.2 Clinical problems  
An overview of the clinical importance of recurrent HSV infections and roles of TLRs in 
HSV diseases is described below. Since TLR functions can also contribute to cancer 







1.2.1 Herpes simplex virus infections  
 
1.2.1.1 Clinical aspects 
Herpes simplex viruses are common human pathogens, which include herpes simplex 
virus -1 (HSV-1) and herpes simplex virus-2 (HSV-2). Primary infection or reactivation of 
HSV can cause a broad spectrum of diseases, such as gingivostomatitis in childhood, 
cold sores (herpes labialis), keratitis, genitalis, and even encephalitis. While Herpes 
labialis (HL) is the most prevalent manifestation of HSV-1 diseases, herpes simplex 
encephalitis (HSE) is the most common cause of sporadic viral encephalitis [15], which 
results in high morbidity and mortality. Moreover, genital co-infection of HSV and human 
immunodeficiency virus (HIV) can accelerate the disease progression to AIDS [16].  
Once infected, the virus becomes latent in the neural ganglions, and reactivates from 
time to time. Although the guanosine analogue acyclovir which interferes with viral DNA 
replication can alleviate the disease, currently there is no biological method to prevent 
the primary infection of HSV, to prevent the establishment of latency, or to eradicate the 
latently-infected HSV. Vaccine developments for HSV are so far inconclusive (reviewed 
in [17,18]).  
Toll-like receptor (TLR) agonists have emerged as an alternative for HSV treatment. For 
example, delivery of the TLR3 agonist poly(I:C) has been shown to increase the survival 
rate in a mouse model of HSE [19], and to protect human neural cells from HSV-1 
infection in an in vitro study [20]. In addition, the TLR7 and TLR8 agonist, Resiquimod 
(R-848), has been applied as a cream in a small randomized controlled clinical study of 
genital HSV-2 infection, which decreased viral shedding rates [21]. However, large 
clinical trials are needed to determine the efficacy of treatment with TLR agonists. 
 
1.2.1.2 Recognition of HSV-1 via TLRs 
HSV belongs to Herpesviridae, which are a family of double-stranded DNA (dsDNA) 
viruses. HSV is in the subfamily of alpha-herpes viruses, and its linear DNA genome is 
encased within an icosahedral capsid, covered by tegument and envelope. TLRs are 
involved in the pathogenesis of HSV infections (Scheme. 1). It has been shown that the 
HSV protein can be recognized by TLR2 and the viral DNA can activate TLR9 signaling 
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[6]. The stimulation of TLR2 by HSV leads to NF-kB activation, and the stimulation of 
TLR9 leads to the production of type I interferons, especially in plasmacytoid dendritic 
cells (pDCs) (Reviewed by Finberg et al. [22]). Although HSV-1 is a dsDNA virus, it can 
produce single- and double-stranded RNA during viral replication. Thus, endocytosis of 
HSV-1-infected cells could make the recognition of viral nucleic acids via TLR3, 7 and 8 
possible.  
 
Scheme. 1: TLR recognition of HSV-1. It is proposed that some proteins on the surface of the virion can 
be recognized by TLR2. The double-stranded HSV-1 DNA viral genome can be recognized by TLR9 in 
the endosome, and RNAs produced during viral replication can be recognized by TLR3, 7 and 8. Double-
stranded viral RNA can also be sensed by another innate receptor, RIG-I, which resides in the cytoplasm 
(not shown). The stimulation of the TLRs leads to the activation of NF-κB. Activation of TLR3, 7, 8 and 9 
especially triggers the secretion of type I interferons in DCs. Type I interferons can further activate IFN-γ 
production in NK cells. 
 
1.2.1.3 TLRs and susceptibility to recurrent HSV-1 diseases 
HSV-1 infects 80-90% of all individuals by mid-life [23]. While most of the HSV-1 carriers 
are asymptomatic, approximately one third suffer from recurrent mucocutaneous 
infections - herpes labialis (HL). It is well known, that in HL-prone individuals potential 
immunosuppressive factors like stress, sun-exposure or infections can trigger the 
outbreak of HL. However, mechanisms underlying the difference of susceptibility to HL 
have been only partially elucidated. Recent findings provide evidence that genetic 
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factors may predispose to HL. Hobbs et al. has mapped a HL susceptibility locus on 
human chromosome 21 through linkage analysis [24]. Furthermore, it has been 
suggested that polymorphisms of apolipoprotein E-(APOE)-ε4, a molecule involved in 
HSV-1 viral entry, is associated with HL [25].  
TLR3 mutation as well as deficiency in a TLR adaptor molecule UNC-93B resulting in 
impaired TLR3, TLR7, and TLR9 activation, were shown in otherwise clinically 
immunocompetent patients with severe HSV-1 reactivation, HSE [26,27]. It is possible 
that defects in TLR signaling also play a role in the susceptibility to recurrent HL. 
 
1.2.2 TLRs and susceptibility to gastric cancer 
Gastric cancer is one of the most common causes of cancer-related death in the world 
[28] and exhibits a clear inflammatory etiology [29,30]. Inadequate elimination of H. 
pylori leads to chronic gastritis and is the most recognized etiological risk factor for non-
cardia gastric cancer [31,32]. However, H. pylori infection alone is not enough to cause 
gastric malignancy, since overall only 10% of infected people develop gastric or 
duodenal ulcers and less than 3% of the infected subjects develop gastric cancer [33]. 
Variations in host genetic factors involved in recognition and cytokine release upon H. 
pylori infection, such as TLRs, IL-1 and TNF- have been reported to be associated 
with risks of gastric cancer (reviewed in [34]).  
On the other hand, it has been shown recently that H. pylori induces innate immune 
response via NOD1 and the TLR-2/1 complex [35,36]. Moreover, dying tumor cells 
release high-mobility-group box 1 (HMGB1), which can stimulate the anti-tumor activity 
of immune cells via TLR2 [37]. Therefore, functional polymorphisms in TLR1 and TLR2 
[38,39,40] might contribute to the susceptibility of gastric cancer. 
 
1.3 Natural killer cell as an important player in viral infections and cancer 
Natural killer cells (NK cells) play essential roles in the immunity to viral infections and 
malignant cells. NK cells are especially important in herpes virus infections, since NK-
deficient patients usually have severe or frequent herpes diseases (as described 
below). Therefore, detecting potential defective TLR responses in NK cells derived from 
subjects with recurrent HSV-1 reactivations is one of the main focus in our study. 
  
13 
1.3.1 Introduction of natural killer cells 
Natural killer cells (NK cells) are derived from lymphoid progenitors in the bone marrow 
and circulate in the peripheral blood. In the early phase of several intracellular 
infections, particularly with herpes viruses and Leishmania, NK cells are profiled by 
accessory cell-secreted cytokines, like type I interferons, IL-12, and TNF-α, to produce 
large amounts of IFN-γ. This is essential for controlling microbes before subsequent 
IFN-γ production of T cells. In addition, using a variety of invariant receptors, NK cells 
are able to recognize the changes of cell surface proteins induced by malignant 
transformation or viral infections, and kill the targets via the release of cytotoxic 
granules (summarized in [41]). There are two main subpopulations of NK cells: CD56dim 
NK cells consist of more than 90% of the NK cells, and are responsible for the cytotoxic 
activities; CD56bright NK cells are the minor subpopulation, and are mainly cytokine 
producers [42,43,44]. 
 
1.3.2 NK cells and herpes virus infections 
NK cells play an important role in the control of chronic herpes virus infections 
(reviewed by Mossmann et al. [45]). For example, NK cells can directly recognize a 
protein of another herpes virus, mouse cytomegalovirus (MCMV) [46]. Defects in NK 
cell IFN-γ production or cytotoxicity have been reported to result in increased 
susceptibility to MCMV [47,48]. Furthermore, mice lacking NK cells are more 
susceptible to both HSV-1 and HSV-2 infections [49,50,51]. In human NK cell deficiency 
syndromes patients are particularly susceptible to recurrent or severe herpes virus 
diseases (including HSV, Epstein-Barr virus (EBV), Varicella zoster virus (VZV), and 
Cytomegalovirus (CMV) ) [52,53]. In fact, NK cells are not only important in the early 
innate immune control of HSV, but are also reported to augment effective adaptive 
immune response against HSV [49]. 
 
1.3.3 Activation of NK cells via TLRs 
NK cells recognize their targets by interplay of activating and inhibitory signals. For 
example, decreased MHC class I expression or increased amount of stress-induced 
NKG2D-ligands can lead to the activation of NK cells (reviewed in [54]). TLRs could 
serve as activating receptors of NK cells. Human NK cells have been reported to 
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express all known TLR mRNAs (TLR1-10), with higher expression levels of TLR2, 3, 5, 
and 6 [55,56]. Ligands for TLR2, 3, 4, 5, and 7 were shown to stimulate IFN-γ secretion 
of NK cells in the presence of a maintenance dose of IL-2 or IL-12 [56,57]. As described 
in the previous section, TLR2 and TLR9 have been shown to trigger the DC response to 
HSV-1 [6], and one of the HSV-1 genes is involved in controlling TLR3 responses [58]. 
Therefore, impairments of TLR responses in NK cells may result in increased 
susceptibility to recurrent or severe HSV-1 diseases. Indeed, Zhang et al.[26] recently 
demonstrated that NK cells isolated from two TLR3-deficient patients with HSE 
displayed impaired IFN-γ response to TLR3 agonist (poly(I:C)) stimulation, while their 
blood DCs responded normally in terms of IFN-α, -β, -γ secretion. However, TLR 
responses of NK cells in UNC-93B-deficient HSE patients have not been studied.  
 
1.3.4 NK cells and tumor immune surveillance 
NK cells and T cells can recognize tumor cells via cancer-induced molecules (NKG2D 
ligands) or tumor-specific antigens. Malignant cells might be eliminated by direct 
cytotoxic activities of these lymphocytes. In addition, IFN-γ produced by NK/T cells is an 
essential anti-tumor cytokine, as mice deficient in IFN-γ have been reported to develop 
spontaneous lymphoma and have increased incidence of lung adenocarcinoma [59]. 
Furthermore, NK cells also contribute to tumor immune surveillance by the induction of 
efficient T cell-mediated anti-tumor immune responses via the release of IFN-γ and 
priming of DCs [60]. In our study, a TLR single nucleotide polymorphism (SNP) was 
found to affect the IFN-γ production of NK cells and T cells. The association of the TLR 
SNP with risk of gastric cancer was examined in the last part of my project. 
 
1.4 Evaluation of TLR function in different subsets of PBMCs 
TLRs are differentially expressed on different subsets of human PBMCs. Most of the 
data obtained so far were done by examining the TLR mRNA level on resting isolated 
cell populations. We should be aware of the possibility that the expression of some 
TLRs might be up-regulated via the interaction between immune cell subsets in the in 
vivo physiology. In order to evaluate TLR responses of each immune cell type 
simultaneously, a multi-color flow cytometric assay was developed in our study to 
assess TLR function in unseparated cells ex vivo.  
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1.4.1 TLR expression on antigen-presenting cells  
Studies of purified human monocytes, myeloid dendritic cells (mDCs), and plasmacytoid 
dendritic cells (pDCs) revealed differential expression of TLRs among each subset 
[55,61,62,63]. Freshly isolated human monocytes express TLR1, 2, 4, 5, 6 and 8, and 
mDCs express TLR1, 2, 3, 5, 6, 8, and 10 (reviewed in [61]). Although TLR4 expression 
on mDC is very low, it has been reported that the TLR4 agonist LPS induces IL-12 
production by most mouse and human CD11chigh DC subsets [63]. DCs are professional 
antigen-presenting cells (APCs), and in humans, mDC and pDC are the two main 
subtypes. Unlike mDCs, isolated human pDCs express only TLR1, 6, 7, 9, and 10 [55]. 
Both types of the DCs can respond to TLR stimulations by producing the inflammatory 
cytokine TNF-α, but pDC precursors, in particular, produce in addition a large amount of 
type I interferons in response to viral infections [64]. The two types of DCs do interact 
with each other. For example, type I interferons derived from pDCs are known to be 
instrumental in activating mDCs [65]. 
 
1.4.2 TLR expression on lymphocytes  
TLR functions have been characterized in cells in the adaptive immune systems 
[66,67,68,69]. B cells express TLR1, 2, 6, 7, 9, 10, and possibly TLR4 and 8 [70]. On 
the other hand, B lymphocytes can be important APCs, and they respond to TLR2, 4, 
and 9 stimulations by producing IL-6, especially in conjunction with CD40 activation 
[71]. TLR 7 and 8 agonist R-848 has also been recognized as a potent B cell stimulator 
[68]. Similarly, T cells, another essential component of the adaptive immune system, 
express several TLRs [55]. MacLeod H and Wetzler LM have written in a perspective 
article [72] that the increasing data which demonstrate expression and activation of 
TLRs on T cells,  provide evidence for a direct role for TLRs in the activation of an 
adaptive immune response. In fact, Imanishi et al. [73] have shown in mice that the 
stimulation of TLR2 on one type of effector T cells, Th1 cells, directly induced IFN-γ 
production, cell proliferation, and cell survival without T cell receptor (TCR) stimulation, 
and these effects were greatly enhanced by IL-2 or IL-12. Human NK cells also express 





1.4.3 Previous assays for evaluating TLR functions 
Genetic defects and polymorphisms in TLR signal transduction have been reported to 
be related to severe viral and bacterial infections [27,74,75,76]. However, people with 
these diseases can show normal quantitative cellular parameters in the current clinical 
assays for innate and adaptive immunity [26,27,77]. Therefore, it is necessary to 
develop a functional assay to detect potential impairments of TLR signaling in patients 
with recurrent viral infections. 
Although scientists have been trying to establish a clinical assay to evaluate TLR 
functions of cells in human peripheral blood [78,79,80], most assays are somehow 
limited. Ida et al. studied the TLR-ligand stimulated cytokine production of peripheral 
blood DC subsets in whole blood [80]. Yet, the frequency of cytokine-positive DCs in 
whole blood was found to be lower when compared to that in freshly isolated PBMC. 
TLR ligand neutralizing factor in serum could be the interference. Deering and Orange 
avoided the influence of soluble factors in whole blood by measuring TNF-α secretion in 
the supernatant of isolated PBMC after different TLR agonist stimulations [78]. 
Nevertheless, TLRs are differentially expressed on different subpopulations of PBMCs 
[55]. Thus, the detection of TLR-defect could have been missed by evaluating the 
cytokine level in the supernatant of the whole PBMC population. 
Furthermore, since all TLRs can trigger NF-kB activation in the final pathways, TNF-α is 
mostly chosen to be the read-out parameter. However, previous assays mainly focused 
on TNF-α  secretion in APCs only, without evaluating the antiviral responses in NK cells 
and lymphocytes [78,79,80]. NK cells, as mentioned in previous sections, are 
particularly important in innate anti-viral and anti-tumor defences. Therefore, we wanted 
to develop a practical multi-color flow cytometry-based assay to evaluate TLR functions 
in different subsets of PBMCs, especially focusing on TLR-induced IFN-γ production in 
NK cells, and its association with recurrent HSV-1 infections and risk of gastric cancer.  
To further find out potential underlying genetic susceptibility mechanisms, subjects were 
genotyped for common TLR SNPs. 
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2 Aims and objectives 
 
Toll-like receptors play important roles in recognizing conserved structures of pathogens 
and endogenous danger signals. TLR-mediated inflammatory responses are essential 
in controlling viral or bacterial infections. Deficiency or over-reaction in the TLR pathway 
results in susceptibility to a wide variety of human diseases and sometimes a poor 
clinical outcome. Polymorphisms in TLR signaling have been reported, which suggest 
heterogeneity of TLR responses among different individuals. TLRs are also expressed 
differentially in human PBMCs. In order to detect potential defects in TLR pathways 
which might be associated with disease susceptibility, we wanted to develop a clinical 
assay to evaluate TLR responses of each cell subset of PBMC.  
Natural killer cells are indispensible in herpes virus infections, and exert vigorous anti-
tumor activity. It has been shown that NK cells can directly respond to TLR stimulations. 
Therefore, we evaluated TLR responses of NK cells and the inter-individual variation of 
these responses. We were interested in the roles of TLR responses of immune cells, 
especially NK cells, in two clinical scenarios: the susceptibility to recurrent orolabial 
HSV-1 reactivations, Herpes labialis (HL); and the susceptibility to gastric cancer.  
The main objectives of our study are as follows: 
 To establish multi-color flow cytometric-assays for the evaluation of TLR 
responses of different PBMC subsets and TLR responses of isolated NK 
cells 
 To analyze the association of differential TLR responses and susceptibility 
to recurrent HL 
 To analyze the association of functional TLR polymorphisms and 
susceptibility to gastric cancer 











3.1.1 Subjects for the study of susceptibility to recurrent herpes labials 
Human peripheral blood was collected from 32 clinically immunocompetent volunteers, 
mean age 29.9±9.8years. 19 of the blood donors had a history of HL (2-4 times/ year), 
while the other 13 donors of similar age and sex had no history of HL. All blood donors 
were free of acute viral infections or HL at the time of evaluation. Serological evidence 
of previous HSV-1 infection was investigated by the Institute of Virology, Charité - 
Universitätsmedizin Berlin. 6 HSV-1-seronegative healthy donors were also recruited. 
35 ml of fresh blood was drawn from each donor into heparin-containing BD Vacutainer 
tubes and used for functional studies. Additional blood donors were further collected for 
TLR3 SNP genotyping, including DNA samples collected from the Institute of 
Microbiology and Hygiene, Charite. A total number of 53 controls and 51 individuals with 
HL histories were genotyped. The research was approved by the Charité institutional 
ethic committee and informed consent was obtained from each participant. 
 
3.1.2 Subjects for the study of susceptibility to gastric cancer 
DNA samples of gastric cancer patients were extracted and genotyped for TLR1 I602S 
SNP by our collaborator, Dr. Lutz Hamann/Prof. Ralf Schumann (Institute for 
Microbiology and Hygiene, Charite, CCM). 
The majority of the patients enrolled were treated at the Robert-Rössle Cancer Center, 
Charité University Medical Center, Berlin-Buch for histologically proven gastric 
adenocarcinoma following surgery. Exclusion criteria were previous gastric surgery, 
preoperative chemotherapy or unknown UICC stage. Patients were followed up in the 
institution’s outpatient clinic. DNA-testing was permitted by written consent including 
DNA-testing before surgery. A total of 291 patients were included and analyzed for TLR-
1 and -2 polymorphisms. In addition, 35 Patients were recruited from an ongoing case-
control study by three different departments of the Charité University Medical Center 
Berlin: A) The Department of General, Visceral, Vascular and Thoracic Surgery; Division 
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of Molecular Biology, Campus Charité Mitte (CCM); B) The Department of Medicine I, 
Gastroenterology, Rheumatology and Infectious Diseases, Campus Benjamin Franklin 
(CBF); C) The Department of Hematology and Oncology, Campus Virchow-Klinikum 
(CVK). As control group, 410 H. pylori-positive patients, proven by urease breath test or 
histology, were recruited. Samples were included if gastric adenocarcinoma was 
excluded by histology [81]. All patients had histologically proven gastric 




3.2.1 TLR agonists 
The TLR ligands used in this study are listed below (Table.1), along with the optimal 
concentrations for inducing maximal TNF-α responses in APCs (monocytes, mDCs, 
pDC and B cells) and IFN-γ responses in NK and T cells. According to manufacturer’s 
suggestions and the concentrations suggested in the literatures, Pam3Cys was titrated 
from10 ng-10 μg/ml, poly(I:C) was titrated from 100 ng-100 μg/ml, LPS was titrated from 
10 ng-1 μg/ml, R-848 was titrated from 100 ng-10 μg/ml, and CpG was titrated from 1-5 
μM.  
 
Table. 1. TLR ligands used to stimulate cells in the study. Pam3CSK4 is an agonist for TLR1/2 





3.2.2 Flow cytometry reagents 
 
3.2.2.1 Antibodies for detecting intracellular cytokine production in APCs 
Productions of TNF-α and IFN-α were detected in monocytes, mDC, pDC and B cells 
with the following monoclonal antibodies:   
Extracellular staining: For up to 2x106 cells in 100 μl volume, 10 μl of PE-conjugated 
BDCA-1 (clone AD5-8E7, Miltenyi Biotec, Germany), 10 μl of APC-conjugated BDCA-2 
(clone AC144, Miltenyi Biotec, Germany), 15 μl of PerCP-conjugated CD14 (clone 
MφP9, Becton Dickinson, Heidelberg, Germany), and 5 μl of APC-Cy7-conjugated 
CD19 (clone SJ25C1, Becton Dickinson) were added. (PE: phycoerythrin, APC: 
allophycocyanin, PerCP: peridinin-chlorophyll-protein complex) 
Intracellular staining: For up to 2x106 cells/100 μl, 0.5 μl of FITC-conjugated TNF-α 
(clone MAb11, Becton Dickinson), 0.5 μl of PE-Cy7-conjugated TNF-α (clone MAb11, e-
Bioscience), or 10 μl of FITC-conjugated IFN-α (clone MMHA-11, PBL Biomedical 
Laboratories) was added. (FITC: fluorescein isothiocyanate) 
 
3.2.2.2 Antibodies for detecting intracellular cytokine production in NK cells and 
T cells 
Productions of TNF-α and IFN-γ were detected in NK cells and T cells with the following 
antibodies: 
Extracellular staining: For up to 2x106 cells/100 μl, 10 μl of PerCP-conjugated CD3 
(Clone SK7, Becton Dickinson), 5 μl of APC-conjugated CD8 (clone RPA-T8, Becton 
Dickinson), and 15 μl of PE-conjugated CD56 (clone B159, Becton Dickinson) were 
added.  
Intracellular staining: For up to 2x106 cells/100 μl, 15 μl of FITC-conjugated IFN-γ 
(clone 25723.11, Becton Dickinson) and 0.5 μl of PE-Cy7-conjugated TNF-α (clone 






3.2.2.3 Antibodies for detecting levels of TLR expression 
TLR expression levels of PBMCs of high and low responders to the respective TLR 
stimulation were evaluated via flow cytometry by using monoclonal antibodies against 
TLR1 (FITC-conjugated, clone GD2.F4, abcam), TLR2 (PE-coupled, clone TLR2.1, e-
Bioscience), TLR3 (PE-labeled, clone TLR3.7, e-Bioscience), and TLR8 (PE-labeled, 
clone44C143, e-Bioscience). The same fluorochrome-labeled isotype-matched 
monoclonal antibodies were used as controls. The mean fluorescence intensities (MFI) 
of the TLR signals were compared to the MFI of the respective isotype controls. 
 
3.2.2.4 Buffers for FACS staining 
PBS+2% Flebogamma (washing buffer, to prevent unspecific binding), 1mM EDTA, BD 
FACS Lysing Solution, BD FACS Permeabilizing Solution (for intracellular staining) 
 
3.2.3 Cytokines and mediums 
a. Co-stimulatory cytokines for TLR stimulations of NK cells and T cells:  
rhIL-12 (1 ng/ml, R&D Systems) , rhIL-15 (1 ng/ml, R&D Systems) 
b. Cytokines for generation of monocyte-derived dendritic cells:  
rhIL-4 (20 ng/ml, R&D Systems), GM-CSF (50 ng/ml, Leukine, Berlex) 
c. Positive control for NK cell and T cell stimulation:  
PMA (phorbol myristate acetate): 100 ng/ml (Sigma, Deisenhofen, Germany) 
Ionomycin: 1 μg/ml (Sigma, Deisenhofen, Germany) 
d. Chemicals to stop cytokine secretion from the cell:  
Brefeldin-A (BFA): 7.5 μg/ml (Sigma, Deisenhofen, Germany) 
Monensin: 2 mM (Sigma, Munich, Germany) 
e. Cell culture medium:  
 RPMI 1640 Medium (Biochrom AG, Germany), containing 10% heat-inactivated 
fetal bovine serum, 1 U/ml Penicillin / Streptomycin, and 2 mM L-alanyl-L-
glutamine; all reagents have been tested for very low endotoxin existence by the 




f. Freezing medium:  
RPMI 1640 Medium (Biochrom AG, Germany), containing 10% DMSO and 36% 
serum; 1 ml of the freezing medium was used to resuspend 107 cells. Freezing 
container (Nalgene Cryo Container) was used to store the ice-cold cells in -80 ۫C 
before transferring to the nitrogen tank. 
 
3.2.4 Cell isolation reagents 
Biocoll (Ficoll) separating solution (density 1.077 g/ml, Biochrom AG, Germany) was 
used after adding RosetteSep NK cell/monocyte enrichment cocktails or before the 
application of MACS NK cell isolation kit.  
RosetteSep NK cell enrichment cocktail (StemCell Technologies): Containing antibodies 
directed against cell surface antigens on human non-NK cells (CD3, CD4, CD19, CD36, 
CD66b) and glycophorin A on red blood cells (RBCs). After centrifugation, the non-NKs 
along with RBCs were at the bottom of the tube.  
RosestteSep monocyte enrichment cocktail (StemCell Technologies): unwanted cells 
were linked to antibody complexes recognizing CD2, CD3, CD8, CD19, CD56, CD66b 
and glycophorin A on RBCs. 
NK isolation kit (MACS, Miltenyi Biotec): untouched NK cells were isolated from PBMCs 
by depleting magnetically-labeled non-NK cells (T cells, B cells, stem cells, DCs, 
monocytes, granulocytes, and erythroid cells). 
 
3.2.5 HSV-1 viral lysate 
The recombinant HSV-1 used in this assay was kindly provided by Yasushi Kawaguchi. 
The UV-inactivated HSV-1 viral lysate was produced by the Charite Institute of Virology 
(kindly provided by Dr. Martin J. Raftery and Prof. Günther Schönrich). HSV-1 (KOS 
strain) was propagated and titered on Vero cells. After 15 minutes of UV inactivation, the 
remaining viral activity was < 10 PFU/μl. HSV-1 viral lysate also contained Vero cell 
debris. The freeze-thaw lysate of Vero cells were used as the control lysate. Both the 
viral lysate and control lysate were titrated and 10 μg/ml was the optimal concentration 




3.2.6 Reagents for DNA extraction and PCR 
a. DNA extraction kit: QIAamp DNA Blood Mini Kit ( QIAGEN) 
b. DNA was extracted from whole blood or frozen PBMC and the concentration was 
determined by measuring OD260 on a spectrometer. The purity of the DNA was 
confirmed by calculating the OD260/OD280 ratio. 
c. PCR: Taq PCR kit (USB Corporation, Cleveland, OH USA); MgCl2, PCR buffer 
and Taq-Polymerase purchased from Applied Biosystems, Rodgau-Jügesheim. 
d. Primers: Primers detecting TLR SNPs are described later in the section “melting 
curve analysis of TLR SNPs” 
e. Gel: 2% Tris-acetate-EDTA /ethidium bromide agarose gels 
 
3.2.7 Reagents for RNA isolation and RT-PCR 
a. Total RNA isolation kit: Nucleospin RNA II extraction kit (Macherey-Nagel) 
b. cDNA synthesis: Quanti Test reverse transcription kit (QIAGEN) 
c. RT-PCR: TaqMan Universal PCR Master Mix (Applied Biosystems) 
d. Primers and probes: Primers and probes for detecting IFN-γ and the house 
keeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) were 
kindly provided by Birgit Sawitzki (Institute of Medical Immunology, Charite, 
CCM). TLR3 TaqMan Gene Expression Assay (Applied Biosystems) was used to 






3.3.1 Cell isolation 
 
3.3.1.1 Isolation of peripheral blood mononuclear cells 
35 ml fresh blood was collected from blood donors. 20 ml of the blood was used for 
PBMC isolation, and the other 15 ml underwent NK cell isolation. PBMCs were 
separated by using Biocoll solution, centrifugation, and were resuspended in 1 ml RPMI 
culture Medium, at 2x106 cells for TLR ligand stimulation.  
 
3.3.1.2 Isolation of NK cells 
NK cells were isolated by adding the RosetteSep NK cell enrichment cocktail (StemCell 
Technologies) to fresh blood. The antibody cocktail connected CD3, CD4, CD19, CD36 
and CD66b, to glycophorin A on red blood cells. The blood-antibody-cocktail mixture 
then underwent the same Ficoll separation steps as PBMC isolation, and the unwanted 
cell populations were discarded with the red blood cells. Purified NK cells were 
resuspended in 1 ml RPMI medium, at 3 x105cells for TLR ligand stimulations. The 
contamination of monocytes and CD3+T cell in NK cell fractions was below 1% (n = 3 
analyses). In some experiments, NK cells were also isolated by MACS NK cell isolation 
kit (Miltenyi Biotec, Bergisch Gladbach, Germany); the purity of NK cells was 95-97%. 
 
3.3.1.3 Isolation of monocytes and generation of monocyte-derived dendritic 
cells 
Monocytes in some individuals were also isolated by using RosestteSep monocyte 
enrichment cocktail (StemCell Technologies). DCs were further generated from isolated 
monocytes: enriched monocytes were cultured in 96 well flat-bottom plate for 7 days in 
complete RPMI medium with IL-4 (R&D Systems) 20 ng/ml and GM-CSF (Leukine, 
Berlex) 50 ng/ml. In co-incubation experiments with 1.5x105 isolated NK cells, 1.5x105 




3.3.2 Toll-like receptor ligand stimulations 
a.  Detection of TLR ligand-induced TNF-α/ IFN-α production in monocytes, mDCs, 
pDCs, and B cells (Antigen presenting cell panel / APC panel): 
 PBMCs (2x106cells/ ml) were treated with Pam3CSK4, Poly(I:C), LPS, 
Resiquimod, OND M362, and the ODN M362 control (Invivogen). 7.5 
μg/ml brefeldin A was added together with or in some experiments 30 
minutes after the addition of the above TLR ligands. 
 Cells were then stimulated for 4 hours at 37۫C incubator. 
 TNF-α / IFN-α secretion in monocytes, mDC, pDC and B cells was 
detected with the fluorescence-conjugated antibodies for flow cytometric 
analysis.  
b.  Detection of TLR ligand-induced IFN-γ production in T cells and NK cells (NK / T 
cell panel): 
 PBMCs (2x106cells/ ml) were treated with rhIL-12 (1 ng/ml) alone or with 
TLR ligands Pam3CSK4, Poly(I:C), LPS, and Resiquimod for 24 hours. 
 7.5 μg/ml of brefeldin A (Sigma, Deisenhofen, Germany) was added for 
the final 6 hours of incubation. 
   IFN-γ secretion in NK cells and T cells were detected with fluorescence-
conjugated antibodies for flow cytometric analysis. 
 
3.3.3 Flow cytometry analysis 
 
3.3.3.1 Staining procedures for extracellular cell markers and intracellular 
cytokines 
After TLR-ligand stimulations, cells were washed with PBS+2% Flebogamma. 1mM 
EDTA was added for 10 minutes at room temperature and washed before the addition of 
antibodies for extracellular staining. The staining of extracellular markers was performed 
on ice for 15 minutes. Cells were then washed and 1x BD Lysis buffer was added for the 
removal of RBCs. Afterwards, cells were permeabilized with 1x BD FACS 
Permeabilizing buffer and stained intracellularly with antibodies against cytokines for 30 
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minutes on ice. Finally, the cells were washed and prepared for flow-cytometric 
analysis. 
 
3.3.3.2 Gating strategies 
a. Detection of TLR ligand-induced TNF-α/ IFN-α production in monocytes, myeloid 
DCs, plasmacytoid DCs, and B cells: PBMCs were first gated according to the 
forward scatter and the sideward scatter. Then monocytes and B cells were 
identified as CD14+ CD19-cells and CD14-CD19+ cells. The mDCs and pDCs 
were identified as CD14-CD19-BDCA1+BDCA2- and CD14-CD19-BDCA1-
BDCA2+ cells, respectively. The proportion of TNF-α-positive cells (%) as well as 
the geometric mean fluorescence intensity (MFI) of TNF-α in TNF-α-positive 
population were determined. 
b. Detection of TLR ligand-induced IFN-γ production in T cells and NK cells: 
Lymphocyte-gate was first determined according to the forward scatter and the 
sideward scatter. Then T cells were identified as CD3+CD56- population, while 
NK cells were identified as CD3-CD56+ population. The NK cells were further 
divided into CD56bright and CD56dim subpopulations. The percentage of IFN-γ-
positive cells and geometric MFI of IFN-γ staining in IFN-γ-positive cells were 
calculated. All data were acquired on BD FACSCanto II flow cytometer, and 
analyzed using BD FACSDiva software v6.0 and FlowJo software v8.8.6. 
  
3.3.4 NK cell degranulation assay 
As previously described by Penack et al. [82], the detection of the lytic granule 
membrane protein CD107a on the surface of NK cells represents degranulation and 
secretion of cytotoxic granules, and its expression showed a good correlation with NK 
cell cytotoxicity. Therefore, we have performed the CD107a assay on 4 individuals to 
determine the ability of their NK cells to degranulate.  
Isolated NK cells were pre-incubated with 1 ng/ml of IL-12 or with medium only for 20 
hours. 2.5 x 104 isolated NK cells were resuspended in 1ml RPMI medium. The NK-
sensitive cell line K562 cells (derived from patient with CML in blast crisis, 
Braunschweig, Germany) were added to isolated NK cells in effectors / target (E/T) 
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ratios of 1:1 and 1:5, in a total volume of 1 ml. Negative controls in the experiments 
were NK cells without the addition of target cells, and positive controls were samples 
treated with PMA/ ionomycin (PAM 100ng/ ml, ionomycin 1 μg /ml; Sigma, Deisenhofen, 
Germany). 20 μl PE-conjugated anti-CD107a antibody (clone H4A3, Becton Dickinson) 
was added during the co-incubation of NK cells and K562 cells. After 1 hour, 20 μl of 
the secretion inhibitor 2 mM monensin (Sigma, Munich, Germany) was added. After 
another 5 hours, cells were washed and stained with PerCP-labeled CD3, APC-
conjugated CD56 (Becton Dickinson), and LIVE/DEAD dead cell stain kit (invitrogen). 
CD107a expression on viable CD3-CD56+ NK cells was analyzed by flow cytometry. 
 
3.3.5 Total RNA isolation 
1 million NK cells purified by MACS human NK cell isolation kit (Miltenyi Biotec) were 
either unstimulated or stimulated with 1ng IL-12 and 50 μg/ml poly(I:C) in 1ml medium 
for 6 hours. Total RNA was isolated using the Nucleospin RNAII extraction kit 
(Macherey-Nagel). Briefly, Cells were washed with PBS and lysed in 350 μl lysis buffer 
(RA1) plus 3.5 μl β-mercaptoethanol. The cell lysate was vortexed vigorously and was 
frozen immediately in liquid nitrogen. Lysed cells were stored at -80 ۫C until more 
samples were collected. Further steps began with lysate filtration, homogenization with 
70% ethanol, and DNA was binded to the column and was digested by rDNase at room 
temperature for 30 minutes. Afterwards, the column membrane was washed and RNA 
was eluted by 22 μl RNase-free H2O, and stored in nuclease-free collection tube at -80 
۫C. 
 
3.3.6 cDNA synthesis 
12 μl RNA (<1 μg) was reverse transcribed by using Quanti Tect reverse transcription kit 
(QIAGEN). Briefly, RNA was denatured at 65 ۫C for 5 minutes, and possible 
contaminating genomic DNA was further cleared by gDNA wipeout buffer at 42 ۫C for 10 
minutes. RNAs were then mixed with reverse transcriptase, RT buffer, and RT primer 
mix. The reaction was performed at 42 ۫C for 30 minutes and the reverse transcriptase 
was inactivated at 95 ۫C for 3 minutes. The synthesized cDNA was stored at -20 ۫C or 4 




3.3.7 Quantitative Real-Time PCR 
IFN-γ and TLR3 mRNA expressions were detected by qRT-PCR. The expression of the 
house-keeping gene HPRT was used as an endogenous control for normalization of the 
amount of sample RNA. The forward and reverse primer mix and TaqMan Probes for 
detecting IFN-γ and HPRT were kindly provided by Birgit Sawitzki (Institute for Medical 
Immunology, Charite, Berlin). Primers and probe for TLR3 was purchased from Applied 
Biosystems as TLR3 TaqMan Gene Expression Assay (amplifying exon 3-4). FAM and 
TAMRA were linked to the 5’end and the 3’end of the probe as reporter and quencher 
dyes, respectively. The TaqMan Universal PCR Master Mix (Applied Biosystems) were 
added to the primer and probe mixture, and together with 1 μl of cDNA resulted in a final 
reaction volume of 13 μl. The reaction mixture were placed in MicroAmp optical tubes 
and caps (Applied Biosystems), and after a short centrifugation, PCR was performed on 
7500 Real-Time PCR System (Applied Biosystems). The PCR reaction started with 50 
۫C for 2 minutes, 95 ۫C for 10minutes, and followed by 40 cycles of 95 ۫C for 15 seconds 
and 60 ۫C for 1 minute.  Data were analyzed by using the Sequence Detector System 
(SDS) software (Applied Biosystems) according to manufacturer’s instructions. All real-
time PCR assays were done in duplicates, and amplification of non-template controls 
and an intron control were included to exclude genomic DNA contaminations.      
Relative IFN-γ mRNA expression level induced by IL-12+poly(I:C) treatment was 
calculated using the ∆∆Ct method using HPRT as reference gene and unstimulated 
cells as baseline. Fold induction of IFN-γ after poly(I:C) treatment = 2-∆∆Ct.  ∆∆Ct = (Ct 
IFN-γ (stimulated) – Ct HPRT (stimulated))-(Ct IFN-γ (unstimulated) – Ct HPRT 
(unstimulated)).  
TLR3 mRNA basal expression levels were compared between poly(I:C)-high 
responders and -low responders: TLR3 mRNA expression in donor A is x fold of the 
level in donor B, x = 2-∆∆Ct . ∆∆Ct = (Ct TLR3 (donor A unstimulated) – Ct HPRT (donor A 
unstimulated))-(Ct TLR3 (donor B unstimulated) – Ct HPRT (donor B unstimulated)).   
 
3.3.8 DNA extraction 
Genomic DNA was extracted from whole blood using QIAamp Blood Mini Kit (QIAGEN). 
Briefly, 200 μl blood stored in EDTA tube at -80 ۫C was equilibrated to room temperature, 
mixed with protease and lysis buffer, and was incubated at 56 ۫C for 10 minutes. 100% 
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ethanol was added, and the mixture was spun through the column. The column 
membrane was washed and the DNA was eluted by 100 μl elution buffer (AE). The 




3.3.9 Melting curve analysis of TLR SNPs 
Genotyping of TLR single nucleotide polymorphism (SNP) was performed by using 50-
100ng genomic DNA and fluorescence-labeled hybridization FRET probes, followed by 
melting curve analysis on a LightCycler (Roche Diagnostics, Mannheim, Germany) as 
described before [40,83].  
The primers and hybridization probes were purchased from TIB MOLBIOL (Berlin, 
Germany). In principle, the ‘sensor’ probe covers the position of the single nucleotide 
variance, and the adjacent ‘anchor’ probe has a much higher melting temperature. 
When samples are steadily heated, the ‘target-probe’ hybrid melts dependent on the 
melting point of the ‘sensor’ probe. Melting of the hybrid causes a spatial separation of 
the dye molecules and a drop in fluorescence, which is detected by the LightCycler. A 
single nucleotide difference will result in a decrease of the melting temperature. 
Primers and probes for detecting TLR1 I602S SNP (rs5743618) were: 
TLR-1 forward: tgtgactacccggaaagttataga, and TLR-1 reverse: cccagaaagaatcgtgcc; 
TLR-1 sensor: ccatgctggtgttggctgtgactgtg-FL, TLR-1 anchor: Red640-
cctccctctgcatctacttggat-pH 
Primers and probes for detecting TLR3 L412F SNP (rs3775291) were: 
TLR-3 forward: ggaagataatgatattccaggcat, and TLR-3 reverse: gcaaaggagttcctagtcagc; 
TLR-3 sensor: tcttggttaggttgaatatgtgtaag-FL, TLR-3 anchor: Red640-
gagaatgagcaagtgatacaaatgtttcat-pH   
 
3.3.10 In vitro UV irradiation of PBMCs 
PBMCs were isolated via Ficoll separation and washed by PBS. 5x105 cells were 
placed in 2 ml PBS per well of the 6-well plate. Half of the plate was covered by foil 
paper as ‘non-UV-irradiated’ controls. The plate was placed on top of a UV-illuminator, 
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which emits UV-light in the UVB range (312 nm) and provides 0.001J/cm2/sec. Cells 
were pulse-irradiated for 20 x 1 second, and received in total 20mJ/ cm2. Afterwards, 
both UV-irradiated and non-irradiated PBMCs were washed with PBS and placed in 1 
ml cell culture medium/ tube. Cells were further stimulated with IL-12 + poly(I:C), or with 
IL-12 alone for 24 hours. IFN-γ production of NK cells was detected by intracellular 
staining and flow cytometry. 
In order to avoid direct UV-irradiation of the NK cells, PBMCs were further separated in 
some experiments by MACS (Miltenyi Biotec) into NK and non-NK populations. The 
non-NK subsets were either UV-irradiated or un-irradiated, and were added back to 
isolated NK cells for poly(I:C) stimulation. 
 
3.3.11 HSV-1 infection of purified NK cells 
The HSV-1 used in this assay was kindly provided by Yasushi Kawaguchi [84]. It 
contains the marker gene venus green fluorescent protein (VGFP), which has been 
inserted into the HSV-1 Us3 gene. 8 x 104 purified NK cells were cultured in 250 μl 
culture medium/ well on a 96-well round bottom plate. NK cells were pre-activated by 
500 IU/ml IL-2 and 15μg/ml PHA for 24 hours before infection. Afterwards, live HSV-1 
was inoculated onto NK cells at a multiplicity of infection (MOI) of 25 for another 24 
hours by Dr. Martin J. Raftery (AG Schönrich, Institute of Virology, Charite, CCM). 
Infected NK cells were detected by examining intracellular GFP signals using 
fluorescence microscope and flow cytometry. 
 
3.3.12 HSV-1 viral lysate stimulation assay 
HSV-1 viral lysate was UV-inactivated and titrated from 2 μg/ml to 100 μg/ml. The 
control lysate (uninfected Vero cells) was also titrated for the same concentration as the 
HSV-1 lysate. 10μg/ml was the optimal concentration for inducing maximal amount of 
IFN-γ production in T cells/ NK cells and the same concentration of the control lysate 
stimulated a low background of IFN-γ production in these cells. 
Human PBMC (2x106cells/ ml) or isolated NK cells (3 x105 cells/ml) were stimulated with 
HSV-1 viral lysate or control lysate in the presence or absence of 1 ng/ml IL-12 for 24 h. 
BFA was added at the last 6 hours. IFN-γ secretions in the NK cells/ T cells were then 
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analyzed via flow cytometry. 
 
3.3.13 Statistical analysis 
a.  Detection of specific TLR-ligand-induced cytokine production in different cell subsets 
in the human PBMC: Non-parametric test was chosen to analyze the data. Data of 
cytokine production in monocytes, mDCs, pDC, B cells and T cells were analyzed from 
8 donors and data of TLR ligand-induced IFN-γ secretion in non-purified and purified NK 
cells were collected from 10 donors. TLR ligand-triggered response was compared to 
the unstimulated samples (paired data). Wilcoxon’s signed-ranks test was applied for 
analyzing the difference between the cytokine production in each cell population in the 
presence or absence of each TLR-ligand.  
 
b. Comparison of different levels of TLR-ligand-induced cytokine in cells of 
asymptomatic healthy subjects and individuals with recurrent herpes labialis: Mann-
Whitney U tests were performed to determine significant differences of the TLR-
responses between the two groups (independent samples). 
 
c. Fisher’s exact test and chi-square test were used to analyze differences of 
frequencies of TLR3 L412F/TLR1 I602S variant allele and proportions of TLR3/TLR1 
genotypes between individuals with and without recurrent HL, respectively. 
 
d. The non-parametric Spearman’s test was applied for correlation studies.  





Part I   Development of multi-color flow-cytometric assay 
 
4.1 Establishment of a multi-color flow cytometric assay to evaluate TLR 
responses in different PBMC subsets  
 
4.1.1 Gating strategies 
A multi-color flow cytometric assay was developed to evaluate TLR responses in 
different PBMC subsets. The assay was divided into two panels: the antigen-presenting 
cell panel (the APC panel) for detecting TLR-ligand-induced cytokines (TNF-α/ IFN-α) in 
monocytes, mDCs, pDCs, and B cells; and the NK cell and T cell panel (NK/T cell 
panel) for detecting TLR-ligand-induced cytokines (IFN-γ/ TNF-α) in NK cells and T 
cells. For detecting the APCs, PBMCs were first gated according to the forward and 
sideward scatters (Fig. 1A). Monocytes were defined as CD14+ CD19- cells, and B cells 
were gated on CD14-CD19+ cells. Cells negative for both CD14 and CD19 were further 
divided into BDCA-1+ cells and BDCA-2+ cells, and were defined as myeloid DCs and 
plasmacytoid DCs, respectively.  For detecting NK and T cells, lymphocyte gate was 
first determined by forward and sideward scatters (Fig. 1B). T cells were detected by 
gating the lymphocytes on CD3+CD56- cells, while NK cells were defined as CD3-
CD56+ cells. The subpopulation of NK cells which express a higher level of CD56 as 
detected by PE-conjugated CD56 antibody (BD Biosciences) was gated for the 
evaluation of the functions of CD56bright NK cells. In some experiments, T cells were 
further gated on CD8 to distinguish the CD8+ from the CD8- subsets. TLR-triggered 
cytokine- producing cells were detected by gating on specific cell surface markers 
against the intracellularly-stained cytokines (e.g. CD14+CD19-TNF-α+ cells represented 







Fig. 1. Gating strategies. (A) Antigen-presenting cell panel. PBMCs were first gated, and divided into 
CD14+ (monocytes) and CD19+ (B cells). The double negative population was then gated on BDCA1 
(marker for mDC) and BDCA2 (marker for pDC). (B) NK/T cell panel. CD3+ cells derived from the 
lymphocyte gate are T cells, and CD3-CD56+ population are NK cells, which were further divided into 
CD56bright (<10% of total NK cells) and dim subsets. 
 
4.1.2 Concentrations of the TLR ligands were optimized and TNF-α and IFN- γ 
production were selected as the read-out of the assay 
Using PBMCs, the TLR ligand concentrations were titrated in the range suggested by 
the manufacturers and previous studies. Pam3Cys was titrated from 10 ng-10 μg/ml, 
poly(I:C) was titrated from 100 ng-100 μg/ml, LPS was titrated from 10 ng-1 μg/ml, R-
848 was titrated from 100 ng-10 μg/ml, and CpG was titrated from 1-5 μM. In case of 
the Pam3Cys-, LPS- and R-848- stimulation, the lowest concentration of the ligand to 
achieve the maximal TNF-α production in monocytes after 4 hours of incubation was 
selected as the optimal concentration for the assay (demonstrated in Table 1). 
Moreover, the optimal concentrations of poly(I:C) and CpG oligonucleotide were 
determined as the ones to induce the maximal cytokine production of myeloid DCs and 
plasmacytoid DCs, respectively.  Both IFN-α and TNF-α secretions in pDCs were 
detected after 18 hours of R-848 and CpG ODN stimulations. However, the TNF-α 
response was more prominent than the IFN-α response (with a 4-fold higher response 
to CpG ODN and a 2-fold higher response to R-848), and could be detected in all cell 
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types of the APC panel 4 hours after all TLR-ligand stimulations. Therefore, TLR-ligand 
induced TNF-α production was determined as the final read-out of the APC panel of the 
assay.  
Similarly, the TLR ligand concentrations in the NK/T cell panel were titrated. Instead of 4 
hours, TLR agonists enhanced significantly the IFN-γ production in NK cells after 24 
hours of stimulation. In the presence of 1 ng/ml IL-12, the fold of poly(I:C)-enhanced 
IFN-γ production in NK cells (12.5-fold) was greater than the fold of increased TNF-α 
(3.4-fold), compared to cells stimulated with IL-12 alone. Furthermore, IFN-γ secretion 
in NK and T cells represents an important effector function in antiviral defences. 
Therefore, IFN-γ was selected as the read-out for the NK/T cell panel. 
 
4.1.3 IL-12 was added for IFN-γ profiling in NK cells and T cells 
Although the NK cells and both CD8+ and CD8- T cells stimulated in the PBMC 
produced significant amount of IFN-γ in response to TLR-ligands (except to type C CpG 
and  in some donors to Pam3Cys), isolated NK cells did not produce IFN-γ in response 
to any of the TLR ligands in the absence of co-stimulatory cytokines (Fig. 2). Therefore, 
for the profiling of IFN-γ production in NK cells, 1 ng/ml of IL-12 was added together 
with the TLR ligands for 24-hour stimulations.  
After the addition of IL-12, we observed that all the TLR agonists, except type C ODN 
M362, enhanced substantially the IFN-γ production in isolated NK cells (Fig. 2). IL-12 
also promoted the TLR-ligand-triggered IFN-γ response in non-purified NK cells. The 






Fig. 2. TLR-ligand-stimulated response in isolated NK cells. The IFN-γ responses of isolated NK cells 
from one donor stimulated with TLR-ligand alone or with the addition of IL-12 for 24 hours are 
demonstrated as a representative. TLR-ligands triggered a substantial amount of IFN-γ production in 
isolated NK cells in the presence of 1 ng/ml IL-12. 
 
4.1.4 NK cells and T cells could not be fully activated if BFA was added before 
TLR-ligand stimulation 
Brefeldin-A (BFA) is known to block most of the cytokine secretions. In order to 
decrease the influence of cytokines secreted by bystander cells and at the same time 
measure the TLR response that is closest to in vivo biology, we added BFA to the whole 
PBMC population along with TLR ligands in some experiments. Instead of adding BFA 
30-60 minutes after TLR stimulation in the antigen-presenting cell panel, BFA was 
added with TLR ligands at the beginning of incubation for 4 hours. Instead of adding 
BFA at the last 6 hours of TLR stimulation in the NK/T cell panel, PBMCs were first 
primed by IL-12 for 6 hours, and stimulated with TLR agonists in the presence of BFA 
for another 18 hours.  
In monocytes, mDCs, pDCs, and B cells, the TNF-α responses to TLR ligands were 
similar when BFA was added immediately prior or half an hour later to TLR agonists 
(Fig. 3A). Interestingly, when BFA was added together with TLR stimulators, the 
responses of NK cells to TLR ligands were much lower (Fig. 3B) and the responses in T 
cells were completely abrogated (Fig. 3C). 
Taken together, the results suggest that although TLR-ligands can stimulate the IFN-γ 
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production in NK cells and T cells in the presence of IL-12, other cytokines or direct 
accessory cell-contact signals are required to fully activate the TLR-induced IFN-γ 
responses of NK cells, and especially of T cells. However, the antigen-presenting cells 
produced TNF-α directly after TLR-ligand stimulation, showing that these cells are 
independent of autocrine/ paracrine signals produced by the PBMC populations in 
response to TLR activation.  
Therefore, in our assay, we have decided to add BFA together with TLR ligands for 
APC panel, and to add BFA at the final 6 hours of 24-hour TLR-ligand stimulation in 






Fig. 3. BFA added together with TLR-ligands decreased bystander cell co-stimulations. BFA was 
added directly with TLR-ligands in these experiments. (A) Compared to the TLR-induced cytokine 
response when BFA was added 30 minutes later, the responses in the APC panel when BFA was added 
together with the TLR ligands were similar (the result shown here is one representative of 3 donors). (B) 
The response of NK cells detected in the PBMCs when BFA was added together with TLR-ligands was 
decreased (n = 4), as compared to the response when BFA was added at last 6 hours (n = 14), although 
the level of response was still higher than the response of isolated NK cells (n = 14), except the response 
to Pam3CSK4. The bar chart represents mean ± SD. (C) The response in T cells when BFA was added 
with TLR-ligands was almost not detectable (n = 5, mean ± SD), as compared with responses of T cells 
when BFA was added at the last 6 hours (n = 5, mean ± SD). 
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4.1.5 Effect of cell cryopreservation 
Next, we sought to validate the assay for cryopreserved cells, since it could be applied 
to more clinical specimens that were properly cryopreserved.  Fresh blood was taken 
from the same individual, and part of it underwent cryopreservation, the other part was 
stimulated directly with TLR-ligands. The cryopreserved PBMCs were kept at least one 
day in the nitrogen tank, and were thawed immediately on the day of experiment. The 
thawed cells were then rested overnight in the 37 ۫ C incubator and stimulated with the 
TLR agonists on the next day. The cryopreserved monocytes produced a similar 
amount of TNF-α in response to TLR-ligand stimulations as the freshly prepared 
monocytes (Fig. 4A); however, the cryopreserved NK cells produced less than half the 
amount of IFN-γ in response to TLR stimulations as compared to fresh NK cells (Fig. 
4B). Therefore, we decided to work with fresh blood in our assay. 
 
 
Fig. 4. Effect of cryopreservation in monocytes (A) and NK cells (B). TLR-ligand-induced cytokine 
productions of cells isolated from fresh blood (ex vivo) were compared with the TLR responses of 










4.2 TLR-ligand-induced cytokine production in different cell subsets detected by 
the assay is in accordance with the literatures 
 
4.2.1 TLR-ligand-induced TNF-α response in monocytes, mDCs, pDCs and B 
cells 
To assess the biological specificity of TLR ligands and their capability to modulate TNF-
α secretion in antigen-presenting cells and B cells, the frequency (%) of TNF-α-
producing cells after different TLR ligand-stimulations was compared to the background 
frequency of TNF-α production in cells incubated with medium only (Fig. 5A). In 
accordance with the TLR expression in each cell type [55,61], Pam3CSK4 (TLR2/1 
agonist) stimulated TNF-α responses mainly in monocytes and myeloid DCs (mDCs), 
and LPS stimulated significant TNF-α secretion in monocytes, mDCs, and B cells. 
Similarly, TLR3 agonist poly(I:C) induced a large amount of TNF-α in mDCs as 
previously reported [85]. R-848, a ligand for TLR7 and 8, triggered the biggest TNF-α 
production in every cell population. And consistently, ODN M362, a type C 
oligonucleotide containing unmethylated CpG motif, showed the specific ability to 
stimulate TNF-α secretion in pDCs and B cells.  However, although isolated human 
pDCs do not express TLR2 and TLR4, considerable amounts of TNF-α responses were 
observed in pDCs within the PBMC after Pam3CSK4 (5.96%±5.48%) and LPS 
(1.98%±1.24%) stimulations, probably due to cell cross talks. 
 
4.2.2 TLR-ligand-induced IFN-γ production in non-purified NK cells and T cells 
We evaluated TLR-ligand-induced IFN-γ productions in NK cells and T cells by 
stimulating PBMCs with TLR1-8 ligands in the presence of 1 ng/ml of IL-12. The 
frequency of IFN-γ positive cells was compared to samples treated with IL-12 alone 
(Fig. 5B). Because antigen-presenting cells can provide signals to NK cells and T cells 
via soluble factors or cell contact [86,87], we investigated the NK cell response to TLR 
ligands in both purified and un-separated populations.  
Poly(I:C), LPS, and R-848 stimulations significantly enhanced IFN-γ secretion of NK 
cells and T cells, as compared to responses triggered by IL-12 only (Fig. 5B, Wilcoxon’s 
signed rank test, all P< 0.05). Isolated NK cells also produced substantial amounts of 
IFN-γ in response to these TLR agonists (Fig. 5B). Responses of isolated NK cells will 
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be described in the next section in detail.  
Interestingly, we observed Pam3Cys-hyporesponsiveness in non-purified NK cells of 5 
donors (Fig. 6). Monocytes and myeloid DCs (mDCs) detected in the PBMC of these 5 
donors, however, showed enhanced TNF-α production to Pam3Cys stimulations (Fig. 
6). These results suggest an inhibitory effect of PBMC population on NK cells in these 
donors.  In order to avoid this inhibitory effect and also to minimize the bystander effect 
of accessory cells, we focused on the TLR responses of isolated NK cells.  
 
 
Fig. 5. Specific responses to TLR stimulations in different cell subsets of human PBMC.  (A) TLR-
induced TNF-α production in APC panel, n = 8, the bar chart represents mean ± SD. (B) TLR-induced 
IFN-γ production in NK/T cell panel, n = 10, the bar chart represents mean ± SD.  : Wilcoxon’s signed 





Fig. 6. Hyporesponsiveness to Pam3CSK4 of NK cells in PBMCs of 5 donors. Pam3CSK4-induced 
responses of monocytes, myeloid DCs (mDCs), and NK cells detected in PBMC, and the response of 
isolated NK cells in 5 donors are demonstrated. Each symbol represents a single donor.    
 
4.2.3 TLR responses in isolated NK cells 
At this point we have optimized the conditions of our assay for the evaluation of TLR 
responses in different subsets of human PBMCs. Since NK cells are critical components 
of HSV-1 infections, we further examined specific TLR ligand-induced responses in 
isolated NK cells in detail. 
As described in the previous paragraphs, TLR agonists triggered negligible IFN-γ 
secretion in freshly isolated NK cells without the addition of co-stimulatory cytokines. It 
has been reported that IL-12 has synergistic effects with TLR agonists and can promote 
IFN-γ production in NK cells [57]. In accordance with the literature, 1 ng/ml IL-12 alone 
resulted in a minimal percentage of IFN-γ-producing NK cells (median 0.5%, range 0.2-
1.9%, n=18); while the addition of TLR2/1 agonist Pam3Cys, TLR3 agonist poly(I:C), 
TLR4 agonist LPS, and TLR7/8 agonist R-848 all enhanced significantly the number of 
IFN-γ secreting NK cells (Fig. 8A-B). The TLR9 agonist ODN M362 (invivoGen), 
however, did not trigger IFN-γ response in isolated NK cells either in the presence or 
absence of IL-12 (data not shown). 
We further compared TLR responses in the CD56 dim (median 96.3%, range 92.7%-
98.6%) and bright (median 3.7%, range 1.4%-7.3%) subpopulations of NK cells. 
Although being a minor subset, the frequency of IFN-γ-producing cells was much higher 
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in CD56bright NK cells: with median 11.3-fold, 1.5-fold, 10.2-fold, and 21.4-fold increase 
in response to Pam3Cys, poly (I:C), LPS and R-848, respectively, as compared with 
CD56bright NK cells stimulated with IL-12 alone, n=18. Representative FACS graphs of 
TLR-triggered IFN-γ responses in CD56bright NK subset are shown in Fig. 8A. 
Frequencies of IFN-γ-producing cells in response to TLR-ligands were compared 
between NK cell subsets in Fig. 8B.  
In addition, we observed considerable inter-individual variations in the responses to TLR 
stimulations, ranging from 1.3-fold to 26.3-fold increase (Pam3Cys), 0.6-fold to 7.0-fold 
increase (polyI:C), 0.7 fold to 27.7 fold increase (LPS), and 1.9 fold to 36.9 fold increase 
(R-848) of IFN-γ-producing NK cells. Furthermore, TLR responses were heterogeneous 
in several subjects, who showed high IFN-γ responses to some TLR ligands and low 
IFN-γ responses to other TLR agonists (data not shown). The magnitude of response 
was, however, highly reproducible. In 6 subjects a second sample was analyzed on a 
different date (over one month period), showing a high correlation (rs= 0.908, P<0.001) 
(Fig. 9). 
Collectively, these results demonstrate that IL-12-preactived NK cells respond to TLR 







Fig. 8. TLR2/1-, TLR3-, TLR4-, and TLR7/8-agonist-induced IFN-γ response in isolated human NK 
cells activated with IL-12 was analyzed by flow cytometry. A: PBMCs were stimulated with IL-12 or 
IL-12 plus TLR agonists for 24 hours. An example of the gating strategy is shown; the percentages of 
CD56bright NK cells producing IFN-γ are shown in the upper right quadrant of each plot. B: Higher 
frequencies of TLR ligand-induced IFN-γ production were observed in the CD56bright NK cell subset. Box-
whisker plot represents median, minimum, and maximum frequencies of IFN-γ positive cells from 18 
donors. Wilcoxon’s signed rank test was performed for detecting differences of NK cell responses to IL-12 




Fig. 9. The magnitude of TLR-agonist-induced response in NK cells from 6 donors was highly 
reproducible. The assay was performed twice for each of these donors on two different dates. Each dot 
represents a result measured at the same time point on date 1 or date 2, and different symbols indicate 







Part II   TLR responses in subjects with recurrent HL  
 
4.3 Detection of TLR responses in different PBMC subsets of subjects with HL 
In the second part of my project, TLR responses in subsets of PBMCs were examined 
in people with histories of recurrent HL.  
 
4.3.1 The amounts of TLR ligand-induced cytokines detected in unfractionated 
APCs, NK cells and CD8+T cells were not different between HL subjects 
and asymptomatic controls 
TLR ligand-induced TNF-α production in monocytes, myeloid DCs, plasmacytoid DCs, 
and B cells were compared within the PBMC population of asymptomatic healthy 
controls (n= 8) and HL subjects (n= 9) (Fig. 10). Similarly, IFN-γ responses triggered by 
TLR1-8 agonists in NK cells and CD8+T cells were also evaluated in the 2 groups. No 
statistically significant difference in the frequency of cytokine-producing cells was found. 
 
Fig. 10. TLR agonist-induced IFN-γ secretion in PBMC subsets of people with recurrent HL and of 
controls. The herpes labialis group is designated as (HL), open circles; n=9. Group of asymptomatic 
healthy controls is designated as (C), closed circles; n=8. The background production of TNF-α in 
unstimulated sample of the APC panel had been subtracted. The background secretion of IFN-γ in 
response to IL-12 had also been subtracted in the NK/T panel. Lines represent medians. Mann-Whitney U 
test showed no significant difference of TLR responses of PBMC subsets between the two groups.  
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4.3.2 Poly(I:C)-triggered responses of purified NK cells are significantly lower in 
subjects with HL 
To study if differences in purified NK cell responsiveness to TLR ligands might correlate 
with susceptibility to HL, NK cells were isolated and stimulated with IL-12 plus agonists 
for TLR2/1, 3, and 7/8, which are the TLRs known to be involved in HSV infections (Fig 
11A-11C). Remarkably, the frequency of IFN-γ-producing purified NK cells in response 
to the TLR3 agonist poly(I:C) was significantly reduced  in the HL group (median, HL vs. 
control: 0.5% vs. 1.4%, P<0.01), while responses to agonists of TLR2/1 (Pam3Cys) and 
TLR7/8 (R-848) were not different (Fig. 11B-C). Cytometric bead array further detected 
decreased IFN-γ production in the supernatant of poly(I:C)-treated isolated NK cells, 
(median 147.7 pg/ml vs. 839.2 pg/ml, P = 0.047) (Fig. 11D). Total RNAs of purified NK 
cells derived from 3 poly(I:C)-high responders in the control group and from 3 donors of 
the HL group (low responders) were extracted after stimulation with poly(I:C) for 6 h. 
Quantitative real-time- PCR (qRT-PCR) showed that the induction of IFN-γ mRNA in HL 
subjects is also impaired (median 165.4 fold vs. 18.8 fold, P = 0.029)(Fig. 11E). Taken 
together, we have detected reduced poly(I:C)-induced IFN-γ secretion in isolated NK 
cells of people with recurrent HL, both at the protein and mRNA levels. 
In order to exclude the possibility that the observed TLR-hyporesponsiveness is merely 
due to an enhancement of a subtle defect in the responsiveness to IL-12 alone, we 
have compared the IFN-γ production of NK cells in controls and HLs after different 
doses of IL-12 stimulations. No significant difference was observed at the IL-12 
concentration (1 ng/ml) we used for IFN-γ-profiling of NK cells in this study (Fig. 11B) or 
at a higher IL-12 concentration (10 ng/ml) (Fig. 11F). Moreover, when we stimulated the 
purified NK cells derived from both groups with PMA/Ionomycin, no difference was 
detected in the level of IFN-γ responses (Fig. 11G), indicating that there is no obvious 
general defect in the ability of NK cells from HL subjects to produce IFN-γ.  
Therefore, our data suggest that the observed poly(I:C)-hyporesponsiveness of purified 





Fig. 11. Poly(I:C)-induced IFN-γ responses in isolated NK cells of HL individuals are lower than 
controls. (A) Purified NK cells were stimulated with TLR agonists in the presence of 1 ng/ml IL-12 for 24 
h. Representative FACS graphs of IFN-γ-producing NK cells in response to different TLR agonists in one 
control and one HL subject are shown. Percentages of IFN-γ-positive cells are marked in the right upper 
corner of each graph. (B-C) IFN-γ responses in isolated NK cells of HSV-1 seropositive asymptomatic 
controls and HL subjects were compared. Control group: n=10, HL group: n= 13. Lines represent 
medians. **P<0.01 by Mann-Whitney U test. n.s.: P>0.05, not significant. (D)  Amount of IFN-γ detected in 
supernatant of isolated NK cells by cytometric bead array after stimulation for 18 h with poly(I:C). Lines 
represent medians. *P<0.05 (E) Total mRNA was collected from purified NK cells stimulated with poly(I:C) 
for 6 h or left unstimulated. Fold induction of IFN-γ mRNA in 3 poly(I:C)-high and 3 poly(I:C)–low 
responders is demonstrated, using HPRT as calibrator. Error bars represent mean±SEM. (F) 10 ng/ml IL-
12 and (G) 100 ng/ml PMA +1 μg/ml ionomycin induced similar levels of IFN-γ responses in isolated NK 
cells of controls and of HL subjects.  
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4.3.3 The percentage of NK cells is lower in people with recurrent HL 
We next examined by flow cytometry the percentage of NK cell subsets within PBMCs 
of individuals with and without recurrent HL. Interestingly, people with HL showed 
significantly lower frequencies of NK cells in the lymphocyte population (median, HL vs. 
control: 12.1% vs. 27.9%, P = 0.019) (Fig. 12). We did not observe a difference in the 
frequencies of other cell subsets. 
 
 
Fig. 12. Percentage of NK cells in lymphocytes of asymptomatic controls and individuals with HL. 
Lines indicate medians. Mann-Whitney U test was performed. 
 
4.3.4 The co-stimulatory function of accessory cells restored the impaired 
poly(I:C) response of isolated NK cells  
It has been reported in two HSE children with TLR3 mutation that although the isolated 
NK cells showed impaired response to poly(I:C), normal IFN-γ production of NK cells 
were observed when stimulated in the presence of APCs [26]. Similarly, we did not 
detect a difference in the NK cell response to poly(I:C) when we compared the IFN-γ 
secretion of NK cells in PBMCs of controls and of HL subjects (see section 4.3.1 and 
Fig. 13A). The data suggest that NK cell hyporesponsiveness to poly(I:C) could be 
restored by accessory cells in the PBMCs. 
To further study if the co-stimulatory effect is mediated by cell-cell contact or soluble 
factors, we conducted co-incubation experiments on two HL subjects who had impaired 
IFN-γ responses to poly(I:C) in their purified NK cells, but high poly(I:C)-triggered 
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responses in the unfractionated NK cells.  NK cells isolated from each donor were 
incubated alone or with the addition of autologous monocytes, monocyte-derived DCs, 
or supernatant collected from poly(I:C)-stimulated PBMCs. We observed that the 
lowered poly(I:C) response of NK cells could be compensated in one donor by DCs and 
in the other by monocytes, while the supernatant had no effect (Fig. 13B). These results 
indicate that co-stimulatory functions of APCs (monocytes, DCs) play an important role 
in restoring the impaired IFN-γ response to poly(I:C) in NK cells of HL individuals.  
 
 
Fig. 13. The co-stimulatory function of APCs restored the impaired poly(I:C)-responsiveness of 
isolated NK cells in some people with HL. (A) poly(I:C)-induced NK cell IFN-γ responses detected in 
the PBMCs of the control and of the HL subjects are shown. Lines represent medians. (B) Isolated NK 
cells derived from 2 HL individuals (HL-1, HL-2), who showed high IFN-γ responses in PBMCs, were co-
incubated with supernatant of poly(I:C)-stimulated PBMCs (Sn), with autologous monocytes (Mo), or with 





4.4 Mechanisms of poly(I:C)-hyporesponsiveness in NK cells 
 
4.4.1 The amount of intracellular TLR3 expression did not correlate with the level 
of poly(I:C)-responsiveness in NK cells  
Differential NK cell responsiveness to poly (I:C) has been suggested to be associated 
with the heterogeneity of TLR3 mRNA transcripts [88]. In order to find out if the ability to 
respond to poly(I:C) stimulation is correlated with the level of TLR3 in resting NK cells, 
we evaluated the amount of TLR3 via flow cytometry. A TLR3 monoclonal antibody 
(cloneTLR3-7, e-Bioscience) and its isotype control were used. Representative flow-
cytometric graphs of TLR3-staining of NK cells are shown in Fig. 14A.  While almost all 
NK cells are positive for intracellular detection of TLR3, only a small subset of NK cells 
express TLR3 on the cell surface. Therefore, we measured the mean fluorescence 
intensity (MFI) of intracellular TLR3, and evaluated the percentage of surface TLR3-
positive NK cells.  
Unlike the previous report, there was no difference in the level of total TLR3 protein 
detected in NK cells derived from 7 poly(I:C)-high and 7 poly(I:C) –low responders (Fig. 
14B, left panel). The quantity of TLR3 mRNA in resting purified NK cells was also 
compared to the fold induction of IFN-γ mRNA after a 6-hour treatment of poly(I:C) via 
qRT-PCR, using HPRT as an endogenous control. No correlation was found between 
the mRNA levels of TLR3 and poly(I:C)-induced IFN-γ in 7 individuals (rs=-0.32, P=0.5). 
We further compared the surface expression of TLR3 in 6 poly(I:C)-high and 6 poly(I:C)-
low responders (Fig. 14B, right panel). Interestingly, three low responders had lower 





Fig. 14. Expression of TLR3 on NK cells and impairments of TLR3 surface expression and 
poly(I:C)-induced IFN-γ production in NK cells of people with homozygous TLR3 L412F genotype. 
(A) A representative histogram of intracellular TLR3 staining (shaded curve indicates isotype staining); 
and dot plots of extracellular TLR3/isotype staining of one donor are shown. (B) Left graph: The mean 
fluorescence intensities (MFIs) of intracellular TLR3 were detected in NK cells of 7 poly(I:C)-high and 7 
poly(I:C)–low responders. ΔMFI: MFI of isotype control staining was subtracted from MFI of TLR staining. 
Right graph: The % of TLR3-surface-expressing NK cells in 6 poly(I:C)-high and 6 poly(I:C)–low 
responders. Lines represent medians. (C) Left graph: Intracellular TLR3 levels of people with different 
TLR3 L412F genotypes are similar. Lines represent medians. Middle graph: Percentage of TLR3-surface-
expressing NK cells is lower in F/F genotype. *P<0.05 by Mann-Whitney U test. Right graph: Poly (I:C)-
induced IFN-γ responses in isolated NK cells derived from donors with different TLR3 genotypes. 
*P<0.05. 
 
4.4.2 TLR3 412 F/F impairs TLR3 surface expression and IFN-γ response to 
poly(I:C) 
The TLR3 L412F genetic polymorphism (rs3775291, Ex4+601C>T) has a high allele 
frequency in Europeans and Asians (~30%). This variant has been reported not to affect 
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the total TLR3 expression level, but can lower the poly(I:C)-mediated NF-κB activity in 
reporter assays [89]. The authors also showed that 293T cells transfected with L412F 
had lower surface expression compared to wild type [89].  
To characterize the functional impact of TLR3 L412F SNP on NK cells, we evaluated 
the TLR3 expression and response to poly(I:C) in subjects with different genotypes.  
There is no difference detected in the intracellular level of TLR3 (Fig. 14C, left panel). 
However, the percentages of TLR3-surface-expressing NK cells derived from 
individuals homozygous for the TLR3 L412F SNP (412F/F) were significantly lower than 
those derived from 412F/L and 412L/L individuals (median 2.5% vs. 4.3%, P= 0.01; Fig. 
14C, middle panel). In line with the expression data, the poly(I:C)-induced IFN-γ 
production in purified TLR3 412F/F NK cells was significantly decreased as compared 
to the IFN-γ response in wild type NK cells (median 0.5% vs. 2.5%, P= 0.03; Fig. 14C, 
right panel). 
To study if there is an association of HL with TLR3 L412F polymorphism, we genotyped 
subjects with and without histories of recurrent HL for TLR3 L412F by PCR and 
subsequent melting curve analysis. Of the 51 HL subjects and 53 controls genotyped in 
this study, we found a trend of higher mutant allele frequency in people with HL (38.2% 
vs. 28.3%, P= 0.08, Table. 2). 
Taken together, our results indicate that the TLR3 L412F homozygosity impairs the 
surface expression of TLR3 and reduces the level of IFN-γ response to poly(I:C) in NK 
cells. Thus, TLR3 412F/F genotype could contribute to the poly(I:C)-






Table 2. Association of TLR3 L412F polymorphism with herpes labialis (HL). aP-value was 
calculated by one-sided Fisher’ exact test for detecting difference of allele frequencies. bP-value was 
calculated by one-sided Fisher’s exact test comparing frequencies of F/F homozygote with frequencies of 
combined heterozygote and wild type individuals in the HL and the control groups. 
 
TLR-3 L412F  
 
N var. allele T (%) 
 
P-valuea 
genotypes (%)  
L/L             L/F           F/F 
 
P-valueb 
HL 51 39 (38.2) 19 (37.3) 25 (49) 7 (13.7) 
control 53 30 (28.3) 
0.08 
25 (47.2) 24 (45.3) 4 (7.5) 
0.24 
 
4.4.3 The poly(I:C)-induced IFN-γ response is highest in HSV-1-seronegative 
individuals 
In previous sections we have compared the TLR responses of people with recurrent HL 
with TLR functions of HSV-1-seropositive asymptomatic controls. During the course of 
our studies we identified 6 individuals without HL histories, who were HSV-1 
seronegative. Of note, 5 of the seronegative donors were TLR3 wild type, with the other 
one being TLR3 L412F heterozygote. Interestingly, poly(I:C)-induced IFN-γ responses 
in NK cells of 5 seronegative subjects tested were significantly higher than those in 
HSV-1-seropositive asymptomatic carriers (median 3.7% vs. 1.4%, P < 0.01) (Fig. 15). 
As described in section 4.3.2, poly(I:C) responses in people with recurrent HL were 
even lower than the levels observed in asymptomatic controls (median 0.5% vs. 1.4%, 
P< 0.01) (Fig. 15). 
These data suggest that the TLR3 response of NK cells might be important not only in 
controlling symptomatic HSV-1 reactivations, but also in protecting from primary HSV-1 





Fig. 15. Isolated NK cells derived from HSV-1-seronegaitve individuals showed highest IFN-γ 
responses to poly(I:C). Isolated NK cells were stimulated with poly(I:C) in the presence of 1 ng/ml IL-12 
for 24 h. Gray dots: HSV-1 seronegative healthy donors; black dots: HSV-1-seropositive, asymptomatic 
individuals; open circles: HSV-1-seropositive subjects with recurrent HL. **P<0.01 by Mann-Whitney U 
tests. Lines represent medians. 
 
4.4.4 Purified NK cells can be infected by HSV-1 when activated 
It is known that HSV-1 proteins interfere with cellular interferon- and TLR- responses, 
thereby promoting viral replication [90,91,92].  In order to exclude that the impaired 
TLR3-induced IFN-γ response in people with recurrent HL was merely due to the 
inhibitory effect of HSV-1 infection in NK cells, we conducted an HSV-1 infection assay 
on purified NK cells. By using a recombinant HSV-1 which contains GFP-conjugated 
Us3 gene, we showed for the first time that isolated NK cells could be infected by HSV-
1, after a 24-hour pre-activation with IL-2 and PHA. Flow-cytometric analysis revealed 
an infection rate of 15.1% and 15.3% in 2 donors analyzed (Fig. 16).  
Taken together, these results suggest that NK cells are under most stimulation 
conditions resistant to HSV-1 infection. Therefore, the reduced TLR3 response 
observed in NK cells of HL subjects is less likely to be due to the suppressive effect of 






Fig. 16. HSV-1 infection of purified NK cells. . Isolated NK cells were infected with GFP-expressing 
recombinant HSV-1 (MOI=25) after pre-activation with IL-2 and PHA for 24 h. Infected NK cells were 
examined via fluorescence microscope (upper panel) and flow cytometry (lower panel). Dot plots of NK 
cells derived from 2 different donors are shown in the lower panel. The percentage of GFP-positive, and 
therefore infected, NK cells is given in the upper right corner.  
 
4.4.5 The cytotoxic potential of NK cells in HL subjects is not impaired 
Reduced NK cell percentages and diminished TLR3-induced IFN-γ production were the 
most prominent findings we observed in subjects with recurrent HL. To address the 
possibility that other NK cell effector functions in HL subjects were also impaired, we 
studied the cytotoxic potential of isolated NK cells in 2 HL subjects whose NK cells 
showed hyporesponsiveness to poly(I:C) stimulations, and compared the results with 
those of 2 asymptomatic healthy controls whose NK cells were highly responsive to all 
TLR agonists. Cytotoxic response was detected by degranulation as assessed by 
CD107a surface expression after co-incubations of IL-12-preactivated NK cells with the 
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NK-target K562 cells (Fig. 17). The IL-12-enhancecd increase of CD107a levels was not 
lower in the 2 HL subjects (low responders) as compared with the 2 controls (high 
responders) (Fig. 17A-B). However, in accordance with a previous study [57], further 
addition of the TLR3 agonist did not increase the IL-12-induced cytotoxicity in both 




Fig. 17. Cytotoxic degranulation as determined by CD107a expression on isolated NK cells of 
healthy controls and HL subjects. Degranulations of isolated NK cells from (A) 2 TLR high responders 
(asymptomatic controls) and (B) 2 TLR low responders (individuals with HL history) are shown. E/T ratio: 
effector (NK cell) / target (K562 cell) ratio. (C) Representative flow-cytometirc histogram of NK cell 
CD107a expression in one donor. Shaded curve: unsimulated NK cells; red curve: stimulated with 1 ng/ml 




4.5 TLR-induced IFN-γ responses of CD56bright NK cells in HL subjects 
As mentioned in the introduction, NK cells can be divided into CD56dim and CD56bright 
subsets. In the first part of the result section we also showed that although CD56bright NK 
cells are the minor population (1.4%-7.3% of total NK cells), a large proportion of these 
cells produce IFN-γ in response to TLR agonist stimulations. Since we have observed 
reduced TLR3-induced IFN-γ in total NK cells of individuals with recurrent HL, we 
wanted to further analyze the TLR-triggered IFN-γ responses in the CD56bright subset.  
 
4.5.1 Reduced IFN-γ response of CD56bright NK cells to R-848 in people with HL  
In resting NK cells, the percentage of CD56bright subsets is similar between HL subjects 
and asymptomatic controls (Fig. 18A). Remarkably, in addition to the diminished 
response to poly(I:C), CD56bright NK cells of individuals with recurrent HL showed also 
reduced IFN-γ response to the TLR7/8 agonist, R-848 ( median of % of IFN-γ-positive 
cells, HL vs. control: 27.0% vs. 49.5%, P = 0.02; Fig. 18B). In contrast, the TLR 
responses of CD56dim cells were similar to those observed in total isolated NK cells, 
since they represent the majority of NK cell population: CD56dim cells of HL subjects 
only showed lowered IFN-γ response to poly(I:C), but not to R-848 (Fig. 18B).  
Furthermore, in order to examine if the IL-12 profiling for R-848 stimulation already led 
to differential up-regulation of CD56 molecule on HL subjects and controls, we analyzed 
the percentage of CD56bright subset after the addition of 1 ng/ml IL-12 alone.  No 
difference was observed between asymptomatic controls and people with recurrent HL 





Fig. 18. Reduced IFN-γ response to R-848 in CD56bright NK cells of HL subjects. (A) Percentage of 
CD56bright subset in total NK cells. (B) IFN-γ response to R-848 in CD56bright and CD56dim subsets of 
asymptomatic controls (n = 12) and of people with recurrent HL (n = 19). *P< 0.05 by Mann-Whitney U 
test. Lines indicate medians. (C) Up-regulation of CD56 after 1 ng/ml IL-12 profiling in purified NK cells of 







4.5.2 Co-stimulatory function of accessory cells restored the reduced IFN-γ 
response of CD56bright NK cells to R-848   
Similar to the findings of poly(I:C)-hyporesponsiveness in total NK cells, the diminished 
R-848 response of CD56bright NK cells derived from HL subjects could be restored when 
assessed within PBMCs (Fig. 19A). Co-incubation experiments of NK cells with 
monocytes, DCs, or supernatant of R-848-activated PBMCs were performed to 
determine the co-stimulatory factor. Interestingly, besides the stimulating effect of 
monocytes and DCs, the addition of R-848-activated supernatant alone could largely 
increase the IFN-γ response of CD56bright NK cells in HL subjects (Fig. 19A).  
These results suggest that soluble factors secreted from accessory cells could restore 
the reduced R-848-response in CD56bright subsets. Since IL-15 has been reported to be 
important in enhancing NK cell activity against in vitro HSV-1 infection [93], we added 
10 ng/ml of IL-15 to isolated NK cells derived from 3 R-848-low responders during R-
848 stimulation. As shown in Fig. 19B, IL-15 could increase the R-848-responsiveness 





Fig. 19. Soluble factors from accessory cells could restore the R-848-hyporesponsivenss of 
CD56bright NK cells. (A) IFN-γ responses to R-848 in CD56bright subset of isolated NK cells were shown. 
In the HL group, addition of monocytes, DCs, and supernatant from R-848-activated PBMCs increased 
the level of CD56bright cell response to R-848. n = 5, error bars represent mean±SEM. (B) The addition of 
IL-15 enhanced the CD56bright NK cell R-848 responsiveness in R-848-low responders. N =3, error bars 
represent mean±SEM. 
 
4.6 IFN-γ response of NK cells to HSV-1 
In previous sections we showed that NK cells could be infected by HSV-1. Moreover, 
we demonstrated that TLR3-hyporesponsiveness in total/CD56dim NK cells and TLR7/8-
hyporesponsiveness in CD56bright NK cells were associated with susceptibility to 
recurrent HL. Therefore, we wanted to further analyze if the IFN-γ response of NK cells 
to HSV-1 is impaired in HL subjects. Supernatants of HSV-1-uninfected and -infected 
NK cells were collected for detection of IFN-γ. However, we could not evaluate the 
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HSV-1 effect; because in order to infect NK cells with HSV-1, purified NK cells need to 
be pre-activated by IL-2 and PHA, which are already strong IFN-γ stimuli.  
Hence, instead of using live HSV-1, we stimulated IL-12-primed PBMCs and IL-12-
activated isolated NK cells with 10 μg/ml UV-inactivated HSV-1 viral lysate or with 
control cell lysate for 24 hours. NK cells (CD56dim and CD56bright subsets) analyzed 
within PBMCs of both the asymptomatic controls and the HL group produced substantial 
amount of IFN-γ in response to HSV-1 lysate (Fig. 20A). Like TLR responses of NK cells 
detected within the PBMC, no difference in response to HSV-1 was observed between 
controls and HL subjects.  
However, when NK cells were isolated, no or rather low IFN-γ responses to HSV-1 were 
detected in both groups even in the presence of 1 ng/ml IL-12 (Fig. 20B).  The result 
suggests that other co-stimulatory signals are needed to fully activate purified NK cells 
to respond to the UV-inactivated HSV-1 lysate. Thus, 1 ng/ml of IL-15, another important 
co-stimulatory cytokine for NK cells, was added to the HSV-1 stimulation. The 
combination of IL-12 and IL-15 did enhance the CD56bright NK cell response to HSV-1 
prominently in 3 of the 6 individuals studied (Fig. 20C). Two of the 3 subjects, whose 
isolated NK cell showed enhanced response to HSV-1 after IL-12 and IL-15 priming, 
belonged to the asymptomatic control group. The other subjects all had a history of 





Fig. 20. HSV-1 lysate-induced IFN-γ production in NK cells.  (A) IFN-γ production of IL-12-activated, 
CD56bright unfractionated NK cells in response to 24h-HSV-1 stimulation. The background level of IFN-γ 
stimulated by 1 ng/ml IL-12 was subtracted. Control group: n=4, HL: n=4. Mean± SEM is presented. (B) 
IFN-γ responses to IL-12+HSV-1 stimulation in CD56bright subset of isolated NK cells. Each symbol 
represents a different individual. Lines represent medians. (C) IFN-γ production of IL-12 and IL-15- 
primed isolated NK cells in response to HSV-1 lysate stimulation. Responses of CD56bright NK cells are 








Part III   Functional impact of TLR1I602S on NK- and T- cells and association 
with gastric cancer 
 
4.7 TLR1 602S/S genotype decreases IFN-γ response to Pam3Cys in NK- and 
CD8+T cells 
In our studies, we did not detect a significant difference in TLR2/1 responses of NK cells 
between asymptomatic controls and subjects with recurrent HL; however, we had 
observed a wide range of NK cell IFN-γ responses to the TLR2/1 agonist Pam3Cys. It is 
known that TLR1 I602S SNP is highly prevalent in the European population, with an 
allele frequency of 75%; and it has been reported to impair the function of TLR2/1 
complex [94,95]. In fact, it is the most common SNP affecting  TLR function identified to 
date [40]. Monocytes derived from subjects homozygous for 602S were found to have 
decreased TNF-α production in response to Pam3Cys, due to impaired receptor 
trafficking [40]. Therefore, in order to find out if TLR1 I602S SNP is correlated with the 
differential Pam3Cys-induced IFN-γ responses observed in our assay, we investigated 
the impact of TLR1 I602S on TLR2/1-triggered IFN-γ production in healthy individuals of 
different genotypes, irrespective of their histories of HL.  
Interestingly, IL-12-activated NK cells detected in the PBMCs of TLR1 602S/S 
homozygous individuals showed significantly lower frequency of IFN-γ-producing cells, 
compared with people of heterozygous and wild type genotypes (p<0.001) (Fig. 21A). 
Similarly, CD8+T cells of people with 602S/S genotype secreted significantly less IFN-γ 
in response to the TLR2/1 agonist, compared with donors of 602S/I and 602I/I 
genotypes combined (p = 0.02) (Fig. 21B). In order to rule out indirect TLR responses 
mediated by accessory cells within PBMCs, NK cells were further isolated. Consistently, 
isolated NK cells of 602S/S individuals demonstrated reduced IFN-γ production after 
Pam3Cys stimulation, as compared with those of the other TLR1 genotypes (median of 
% of IFN-γ-producing NK cells: 0.6% vs. 7.8%; p = 0.007) (Fig. 21C). We could not 
analyze the Pam3Cys response in isolated T cells since T cells require the co-
stimulatory function of antigen presenting cells to respond to Pam3Cys (please refer to 
section 4.1.4). 
In accordance with previous report [40], monocytes derived from donors with 602 I/S 
and 602 I/I genotypes produced significantly larger amount of TNF-α in response to 10 
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ng/ml Pam3Cys, as compared with monocytes of 602 S/S donors (P = 0.02, Fig. 22). 
The difference became less prominent at higher Pam3Cys concentrations (Fig. 22). 
 
 
Fig. 21. TLR2/1-induced IFN-γ production is impaired in NK cells and CD8+T cells of TLR1 602S/S 
homozygous people. (A) and (B): IFN-γ responses were detected in NK cells and CD8+T cells within 
the whole PBMCs via flow cytometry. TLR1 602S/S, n=10; TLR1 602S/I, n=6; TLR1 602I/I, n=4.  (C) IFN-
γ responses of isolated NK cells derived from donors with different TLR1 genotypes. TLR1 602S/S, n=7; 
TLR1 602S/I, n=3; TLR1 602I/I, n=4. Two-tailed exact P value was determined by Mann-Witney U test 
comparing homozygous versus combined heterozygous and wild type donors. The lines represent 






Fig. 22. TNF-α production by monocytes of different TLR1 genotypes in response to Pam3Cys. 
Monocytes were stimulated with other cells of PBMC for 4 hours with medium only (Med) or with different 
concentrations of Pam3Cys for 4 hours. Each dot represents mean ± SEM, n=3. Mann-Whitney U test 
was performed to compare the responses between the homozygous people and the combination of 
individuals with wild type and heterozygous alleles. *: P < 0.05  
 
4.8 TLR1 I602S SNP and susceptibility to recurrent HL 
It has been reported that DCs recognizes HSV via TLR9 and TLR2, which forms hetero-
dimmers with TLR1 or TLR6 [6]. Therefore, although we did not observe TLR2/1 
hyporesponsiveness in NK cells derived from HL subjects, we genotyped 20 HL 
subjects and 22 asymptomatic controls for TLR1 I602S SNP (Table. 3). In accordance 






Table 3. Association of TLR1 I602S polymorphism with HL. a P-value was calculated by Fisher’s exact 
test for difference in allele frequencies. b P-value was calculated by chi-square test for differences in 
genotype frequencies. 
 
TLR-1 I602S  
 
N var. allele G (%) 
 
P-valuea 
genotypes (%)  
I/I             I/S           S/S 
 
P-valueb 
HL 20 29 (65.9) 3 (15) 9 (45) 10 (50) 
control 22 25 (62.5) 
0.82 
3 (13.6) 9 (40.9) 8 (36.4) 
0.94 
 
4.9 Association of TLR1 I602S and gastric cancer 
As described in the introduction, IFN-γ secreted by NK cells and T cells are essential 
anti-tumor effectors [59,60]; and H. pylori, an important etiological factor for gastric 
cancer, can be recognized via TLR2/1 complex [36]. Therefore, the TLR1 I602S SNP 
impairing the IFN-γ responses of NK cells and CD8+T cells might play a role in the 
susceptibility to gastric cancer. 
 
4.9.1 TLR1 602S/S genotype is associated with susceptibility to gastric cancer 
With the help of Dr. Lutz Hamann (Schumann Lab, Institute for Microbiology and 
Hygiene, Charite, who provided table 4-6) and Departments of Gastroenerology and 
Hematology/Oncology in Charite University Medical Center, we genotyped 326 gastric 
cancer patients and 410 controls (H. pylori-positive, without gastric cancer) for TLR1 
I602S. Another functional SNP, TLR2 R753Q, was also investigated for comparison. We 
did not detect any significant association of the allele frequencies with gastric cancer 
(Table 4). However, the presence of the homozygous TLR1 602S/S genotype was 
significantly associated with susceptibility to gastric cancer (P = 0.03). TLR2 753Q/Q 
homozygosity, on the other hand, exhibited no significant association with gastric cancer 




Table 4. Association of TLR1 I602S and TLR2 R753Q polymorphisms with gastric cancer. a P-
values were calculated by Fisher’s exact test for difference in allele frequencies. b P-values were 
calculated by chi-square test for differences in genotype frequencies; c Some DNAs gave no results for 
TLR-2 R753Q genotyping.  
 








I/I                I/S              S/S 
 
P-valueb 
Gastirc cancer 326 498(76.4) 27(8.3) 100(30.1) 199(61.0) 
control 410 596(72.7) 
0.12 
30(7.3) 164(40.0) 216 (52.7) 
0.03 
        
 








R/R                R/Q              Q/Q 
 
P-valueb 
Gastirc cancer 318c 21(3.3) 298 (93.7) 19 (6.0) 1 (0.3) 
control 410 33(4.0) 
0.49 




4.9.2 TLR1 602S/S genotype is not associated with susceptibility to H. pylori 
infection 
Since TLR1 is involved in the recognition of H. pylori, we wanted to investigate if TLR1 
602S/S genotype results in higher susceptibility to H. pylori infection, and hence leads 
to an increased risk of gastric cancer. The information about the presence of H pylori 
was unavailable in this gastric cancer cohort. However, it is well known that cardia 
gastric cancer is not driven by H. pylori infection. We therefore compared the TLR1 
genotype frequency between patients with cardia- and non-cardia gastric cancers 
(Table. 5). There was no significant difference detected, which indirectly suggests that 
H. pylori-mediated chronic inflammation might not be the cause for the observed TLR1 




Table 5. TLR-1 I602S SNP is not associated with the localization of gastric cancer. a P-values were 
calculated by Chi-square test. b some samples of unclear localization were excluded.  












      
wild type 5 (7.9%) 4 (6.6%) 6 (7.1%) 9 (8.7%) 1.0 
Heterozygous 20 (31.7%) 19 (31.1%) 22 (26.2%) 35 (33.7%) 0.9 
homozygous 38 (60.3%) 38 (62.3%) 56 (66.7%) 60 (57.7%) 0.9 
N = 312 b 63 61 84 104  
 
 
4.9.3 TLR1 I602S is associated with metastasis 
To further characterize the impact of TLR1 I602S on the course of gastric cancer, we 
evaluated the association of TLR1 SNP genotype with the percentage of patients who 
had distant metastasis when gastric cancer was diagnosed. Remarkably, patients 
carrying the variant TLR1 602S allele showed increased frequency of gastric cancer 
metastasis at the time of diagnosis, as compared to wild type-allele carriers (P = 0.04, 
Table 6). Of note, the TLR1 I602S heterozygotes, who did not show elevated risks for 
primary gastric cancer, also exhibited higher frequencies of metatstasis in comparison to 






Table 6. TLR1 I602S variant allele is associated with presence of metastasis. a P-value was 
determined by Fisher’s exact test comparing wild type patients versus combined heterozygous and 
homozygous allele carriers.  
 
TLR-1 I602S  
 
genotypes  
I/I                I/S              S/S 
 
P-value a 
With metastasis 4      39    60 







Part I     About assay development 
 
5.1  Establishment of a multi-color flow cytometry-based assay for the 
evaluation of TLR functions in different cell subsets of PBMC 
In this study, we have established a multi-color flow cytometric assay which allowed us 
to detect the TLR responses in various PBMC subsets simultaneously. Previous assay 
developed by Deering and Orange [78] for the evaluation of TLR function assessed TLR 
responses in the supernatant of PBMCs, thus not allowing the attribution to cell 
subpopulation. In addition, multi-color flow cytometric-based assays have been 
described to assess TLR responses in cell subsets. To date, 4-, 6- and 8-color flow 
cytometric assays for TLR responses were developed [80,96,97]. However, these 
assays all focused on the conventional antigen-presenting cells, namely DCs and 
monocytes. Functional assays to determine TLR responses of NK cells have not been 
described so far. In viral infections, NK and T cells play an important role, and impaired 
DC-dependent NK cell and T cell responses to TLR ligands have been reported in 
human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections [98,99]. 
Importantly, in TLR3-deficient patients with HSE, their isolated NK cells showed 
impaired IFN-γ production in response to poly(I:C), but their blood DCs responded 
normally[26]. Therefore, by including the TLR-induced IFN-γ responses of NK cells and 
T cells in the panels, our assay provides the most comprehensive aspects of TLR 
responses, thus increasing the sensitivity of detecting potential impairments in different 
immune cell subsets.  
In general, the TLR-induced TNF-α or IFN-γ production in each cell subset evaluated in 
our assay were in agreement with previous reports, except that TNF-α production of 
pDCs was observed after stimulation with TLR2 and TLR4 agonists, which might be due 
to cross talks of pDCs with other cells in peripheral blood. In T cells, the IFN-γ response 
was completely abrogated when BFA was added at the beginning of TLR stimulations, 
indicating a strong dependence of T cell-TLR responses on accessory cell cytokines. In 
contrast, isolated NK cells, especially the CD56bright subset, still exerted significant 
production of IFN-γ in response to TLR stimulations when BFA was added at the 
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beginning of TLR stimulations.  
Cryopreservation of PBMCs in our experiments was possible for evaluating TLR-ligand 
triggered TNF-α production in monocytes, but the freeze-and-thaw procedure altered 
the IFN-γ responses to TLR-ligands in NK cells. Deering and Orange [78] had observed 
a greater TLR-ligand-induced TNF-α response in cryopreserved cells; however, we did 
not detect this phenomenon in our assay. It might be that instead of using the rapidly 
thawed cells immediately, we had rested the thawed PBMC overnight, thus decreasing 
the stress-induced release of cytokines. 
Furthermore, large inter-individual differences in TLR-induced TNF-α and IFN-γ 
responses were observed in our assay. Interestingly, some donors were high-
responders to certain TLR ligands, but low-responders to other TLR agonists. The 
individual TLR response was highly reproducible one month later. These data suggest 
that genetic polymorphisms of TLR pathways might underlie the heterogeneous TLR 
responses.  
 
5.2 Direct TLR responses of NK cells 
In accordance with previous studies [56,57,100], we demonstrated that in the presence 
of IL-12, TLR2/1, 3, 4, 7 and 8 agonists were able to stimulate IFN-γ secretion in 
purified human NK cells. In peripheral blood, the NK population is consisted of more 
than 90% the CD56dim NK subset and less than 10% of the CD56 bright cells. These two 
main NK cell subpopulations show differences in both phenotypes and functions, as 
reviewed in [101,102]. The CD56dim NK cells have higher cytotoxic potentials than the 
CD56bright subset, and they express much higher levels of the Fc gamma receptor III 
CD16, which mediate the antibody-dependent cellular cytotoxicity efficiently. The 
CD56bright NK cells, on the other hand, express the high affinity-receptor for IL-2, and 
have higher capacity to produce abundant cytokines when activated. With the 
preactivation of IL-12 and IL-18, the CD56bright NK cells secrete 20-30 times more IFN-γ 
than CD56dim NK subsets [103]. Similar to these findings, we found that CD56bright NK 






Part II  Association of differential TLR responses of NK cells and 
susceptibility to recurrent HL  
 
5.3 TLR3- hyporesponsiveness of NK cells in subjects with recurrent HL 
NK cells play essential roles in HSV infections. Both quantitative and qualitative 
deficiencies of NK cells have been reported to result in severe or frequent herpes virus 
infections [52,53]. In this study we analyzed patients suffering from the milder, however, 
very common symptoms of HSV-1 reactivation with lesions confined to the orolabial 
region. Remarkably, we observed not only lower percentages of NK cells in people with 
HL, but also demonstrated here for the first time that the poly(I:C)-induced IFN-γ 
response of purified NK cells is significantly lower in people with recurrent HL, indicating 
that the TLR3 response of NK cells is important for the control of HSV-1 infections.  
 
5.3.1 NK cell hyporesponsiveness to poly(I:C) could be restored by co-
stimulatory function of APCs 
It is interesting to note that NK cells of HL subjects produced as much IFN-γ as 
asymptomatic controls when stimulated in the presence of other cell subsets of PBMC. 
We further demonstrated that the impaired poly(I:C) response of NK cells could be 
restored by the addition of DCs or monocytes, but not with supernatant collected from 
poly(I:C)-stimulated PBMCs, suggesting co-stimulatory effects of APCs via cell-contact-
dependent signals or high concentrations of cytokines at the interface of APCs and NK 
cells.  
It has been reported that poly(I:C) can trigger the cellular interferon response via TLR3 
and RIG-like receptors (RLRs, including RIG-I and MDA-5) [104]. TLR3 senses dsRNA 
on the cell surface or in the endosome; while RLRs are cytosolic dsRNA sensors. 
Although we applied poly(I:C) extracellularly without transfection in our study, it is 
suggested that poly(I:C) could penetrate into the cytoplasm through yet unknown 
mechanisms [105]. APCs and NK cells express both TLR3 and RIG-I/MDA-5. However, 
unlike professional APCs / epithelial cells which might utilize TLR3 and other pattern 
recognition molecules (such as RLRs) cooperatively in response to poly(I:C)  or RNA 
virus stimulations [104,106,107], human NK cells have been reported to recognize 
poly(I:C) via TLR3 only [87]. In line with these data,  Zhang et al.[26] reported that 
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TLR3-deficient human DCs and keratinocytes could still produce substantial amount of 
IFN-α and - in response to poly(I:C), while their isolated NK cells showed impaired 
poly(I:C)-induced IFN-γ production. Furthermore, professional APCs such as DCs 
express diverse and high levels of pattern recognition molecules and thus might be 
more sensitive to poly(I:C) stimulations.  
Therefore, we propose that although HL subjects have a deficiency in TLR3 responses;  
their APCs are more sensitive to poly(I:C) stimulation than lymphoid cells, perhaps by 
enhanced synergy between pattern recognition molecules, thus allowing them to 
compensate for the impaired TLR3 responses in NK cells (depicted in Scheme 2A). 
It is well-known that psychological stress, UV-exposure, and superimposed infections 
can lead to symptomatic HSV-1 reactivation. In fact, it has been suggested that UV-
exposure can down-regulate the co-stimulatory function of DCs [108]. Moreover, the 
stress cytokine glucocorticoid has been shown to directly suppress the TLR3 expression 
and poly(I:C)-induced NF-κB activation in epithelial cells [109]. NK cell numbers in 
stressed mice have also been found to be decreased significantly [110]. Collectively, 
these data suggest that people who already have a reduced NK cell number and 
impaired TLR3 responses might be more susceptible to suffer from HL outbreaks when 
under stress (depicted in Scheme 2B). In my study, I have attempted to evaluate the 
differential impact of UV irradiation on unfractionated NK cells of HL subjects and of 





Scheme 2. Model of co-stimulation of APCs on restoring the impaired TLR3-induced IFN-γ in NK 
cells and the effects of stress. (A) HSV-1 promotes secretion of co-stimulatory cytokines in DCs and 
keratinocytes via TLR3-dependent and –independent pathways, which boosts the IFN-γ production in 
TLR3-deficient NK cells. (B) Stress can down-regulate cytokine secretion of co-stimulatory cells. Also, 
stress can directly alter TLR3 pathway and NK cell numbers, leading to further decrease of NK cell IFN-γ 





5.3.2 Mechanisms of NK cell hyporesponsiveness to poly(I:C) in people with 
recurrent HL  
Unlike the findings of Sivori et al. [88], we did not observe an association between the 
total amount of TLR3 mRNA/protein and NK cell response to poly(I:C). In order to find 
out if TLR3 SNPs might impair the level of poly(I:C)-induced IFN-γ production, we 
studied the functional role of TLR3 L412F. This SNP is prevalent in 25-30% of our 
population and has been shown to impair the NF-κB activity and interferon responses in 
reporter assays following poly(I:C) stimulation [89]. It has been reported to be 
associated with less efficient immunity after vaccination against measles virus [111] and 
a very recent report suggested that TLR3 L412F also plays a role in host susceptibility 
to coxsackievirus B3-mediated myocardidits [112]. Functional assays on NK cells of 
different TLR3 L412F genotypes revealed that the homozygous variant allele-carriers 
showed decreased IFN-γ production in response to poly(I:C), as compared to wild type. 
In contrast to DCs, a subset of NK cells do express TLR3 on the cell surface [87]. Very 
interestingly, we observed lower TLR3 surface expression in NK cells of HL subjects as 
well. These data are in accordance with the findings of Ranjith-Kumar et al. [89], that 
TLR3 L412F is under-represented on the surface of transfected 293T cells and impairs 
the poly(I:C) response, while the intracellular TLR3 variant level is normal. Remarkably, 
individuals with recurrent HL showed a higher TLR3 L412F frequency and a higher 
proportion of homozygous 412F/F genotype, although our analyses did not reach 
statistical significance. The statistics might be affected by the fact that several F/F 
homozygous healthy controls detected in our study are relatively young (20 – 25 years 
old); therefore they might develop HL later in life. Moreover, other mechanisms of 
susceptibility to recurrent HL exist, as discussed later in section 5.3.5. 
 
5.3.3 Possible influences of TLR3-hyporesponsiveness on the interplay of NK 
cells and T cells 
TLR3-hyporesponsiveness of NK cells might contribute indirectly to reduced T cell 
responses to HSV-1. It has been discovered that cytokines secreted by NK cells are 
required for optimizing the quality of HSV-1-specific CD8+T cell responses [49]. It is also 
shown that TLR3 is indispensible for gB-specific CD8+T cell response to HSV-1 [113], 
and pre-treatment with the TLR3 agonist poly(I:C) could protect human neuronal cells 
from HSV-1 infection [20]. Since IFN-γ secreted by CD8+T cells surrounding latently-
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infected neurons was described to be the key player in preventing HSV reactivations 
[114,115], we propose that TLR3-deficient NK cells, which produce less IFN-γ, would 
reduce the number of multi-functional HSV-1-specific CD8+T cells, thus lowering the 
threshold of HL outbreak. 
 
5.3.4 Highest NK cell TLR3 response in HSV-1-seronegative people  
In the course of this study, we identified 6 HSV-1 seronegative donors. Of note, 5 of 
these individuals are TLR3 wild type, and demonstrated significantly higher NK cell IFN-
γ responses to poly(I:C), as compared to the responses of HSV-1-positive 
asymptomatic carriers. Although we could not be sure if these individuals have 
encountered the virus before, chances of HSV-1 exposure due to family members with 
recurrent HL or lab exposure to HSV-1 were possible in 4 of the 6 subjects. It has been 
reported that some HSV-seronegative people could mount persistent HSV-specific T cell 
responses in the absence of seroconversion, suggesting viral elimination or 
containment of infection [116]. Whether the high TLR3-response of NK cells contributes 
to the resistance of HSV-1 infection requires further investigations. 
 
5.3.5 Other possible genetic susceptibilities to recurrent HL  
Our data suggest the TLR3 412F/F genotype as a risk factor of HL only for a subgroup 
of patients. Deficiencies of other adaptor molecules on the TLR3-signaling pathway 
could also contribute to the observed poly(I:C)-hyporesponsiveness. Interestingly, in an 
updated report written by Casanova’s group [117], only 1 in 45 HSE patients sequenced 
for UNC93B and TLR3 genes showed the disease-predisposing mutations as previously 
described by the same group. However, some of these patients still displayed functional 
defects in the TLR3-IFN-/-/- pathway, indicating involvement of other TLR3-signaling 
associated genes.  
Furthermore, the overlap in TLR3 responsiveness of healthy and HL people observed in 
our study suggests that different mechanisms underlying the susceptibility to HL exist, 
such as the recently described HL susceptibility locus on human chromosome 21 [24] or 
polymorphisms of apolipoprotein E-(APOE)-ε4 [25]. In fact, when we examined the TLR 
responses in the CD56bright NK subset, reduced IFN-γ response to the TLR7/8 agonist 
R-848 was observed in HL subjects. Our data suggest that functional polymorphisms in 
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TLR7 or 8 [118,119] might also play a role in susceptibility to recurrent HL.  
Unlike the poly(I:C)-hyporesponsiveness of total NK cells, the reduced CD56bright cell 
response to R-848 could be restored by soluble factors in the TLR7/8-stimulated 
PBMCs. We have demonstrated that one of these co-stimulatory factors could be IL-15, 
a cytokine important for NK cell activation, proliferation, and control of HSV-1 infection 
[93,120,121].  Since monocyte is one of the main sources of IL-15 [122], it is possible 
that the very few contaminating monocytes (<1%) in our purified NK cell culture had 
diminished IL-15 response to R-848.  It is known that IL-15 utilizes components of the 
IL-2 receptor to activate human NK cells [123]. Because the CD56bright NK subset has 
the high affinity IL-2 receptor [102], they are probably more susceptible to the minor 
variations of IL-15 level in culture medium. Hence, these data might explain why the R-
848-hyporesponsiveness in NK cells of HL subjects was only detected in the CD56bright 
subpopulation. 
  
5.4 NK cells and HSV-1 
Our results show that TLR3 response of NK cells is associated with susceptibility to HL. 
However, how could NK cells recognize HSV-1 via TLR3? HSV-1 is a double-stranded 
(ds) DNA virus, which could produce dsRNA during erroneous converging bidirectional 
DNA transcription. Although TLR3 could recognize dsRNA, it has been reported that 
dsRNA is accumulated in the cytoplasm after HSV infection via unknown mechanisms 
[124]. Therefore, HSV dsRNA produced during viral replication could be recognized by 
cytosolic RLRs. However, unlike TLR3, which has been reported to be involved in HSV-
1 encephalitis, clinical importance of RLR in HSV infections is less understood. On the 
other hand, it is conceivable that NK cells might sense dsRNA derived from adjacent 
HSV-1-lysed cells directly via cell surface TLR3, or via endosomal TLR3 through 
endocytosis of cell debris containing viral replication intermediates. In addition, cytosolic 
viral nucleic acids could be delivered to endosome via autophagy, and stimulate host 
interferon response [125]. Fusion of autophagosome with endosome makes the 
recognition of dsRNA via TLR3 possible,  
 We further addressed the question whether NK cells can be infected by HSV-1 at all. 
We show here for the first time that similar to T cells [126,127], about 15% of NK cells 
could be infected after pre-activations of  IL-2 and PHA. It has been reported that 
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receptors for HSV viral entry are expressed on activated lymphocytes [128]. The 
requirement of PHA activation, however, suggests that NK cells, which are important in 
controlling HSV-1 infections, are relatively resistant to HSV-1 invasion. Since it is 
described that viral proteins produced during active HSV-1 infection can inhibit or lower 
cellular interferon responses [91], our findings that NK cells are less vulnerable to HSV-
1 infection exclude the possibility that the reduced TLR3 responses observed in HL 
subjects were merely due to direct blocking mechanisms of HSV-1.  
Moreover, we have evaluated NK cell IFN-γ responses of HL subjects and controls 
toward HSV-1. However, we did not succeed in analyzing live-HSV-1-induced IFN-γ, 
because NK cells need to be pre-activated by IL-2 and PHA, which already up-regulate 
IFN-γ. By using UV-inactivated HSV-1 lysate, we detected similar IFN-γ responses in 
PBMCs derived from asymptomatic controls and HL subjects. However, unlike the 
responses to TLR-ligands, isolated NK cells responded poorly to HSV-1 lysate plus IL-
12, indicating the requirement of other co-stimulatory cytokines or viral replication (to 
produce dsRNA). The addition of IL-15 promoted IFN-γ production in response to HSV-
1 lysate in 3 individuals tested. Although these 3 donors were high responders to 
Pam3Cys, further investigation on 22 HL subjects revealed that the functional TLR1 
I602S SNP might not be associated with susceptibility to HL. Interestingly, as we later 
found out, these 3 individuals were of TLR1 602I/I (wild type) genotype, who exhibited 
higher IFN-γ response to TLR2/1 stimulations. These results suggest that although UV-
inactivated HSV-1 lysate was not replicative, thus might not be able to stimulate TLR3, 7 
and 8 in isolated NK cells;  glycoproteins/lipoproteins on the viral surface might still 










Part III  Functional impact of TLR1 I602S on NK cells and CD8T cells and 
association with gastric cancer  
 
5.5 TLR1 I602S SNP impairs IFN-γ secretion in NK cells and T cells 
TLR1 acts as a coreceptor for TLR2, and the TLR2/1 complex can recognize lipopeptide 
components of microorganisms. The TLR1 I602S SNP, which is prevalent in Europeans, 
has been shown to impair TLR1 trafficking to the cell surface, and reduce the NF-
kB/TNF-α responses to Pam3Cys in transfected HEK293 cells and primary human 
monocytes [40,95]. In our study, we have observed Pam3Cys-hyporesponsiveness not 
only in monocytes, but also in NK and CD8+T cells of TLR1 602S homozygous 
individuals. The impaired IFN-γ response observed in both unfractionated/isolated NK 
cells and unfractionated T cells suggest that the TLR1 602S/S genotype could alter the 
function of innate and adaptive immunities. Thus, the global effect of homozygous TLR1 
602S allele on immune cells led us to the suspicion that the SNP might be involved in 
anti-tumor defences as well. Indeed, we later found an association of TLR1 I602S SNP 
with susceptibility to gastric cancer.   
Of note, in contrast to previous findings [40] we did not observe a down-regulation of 
surface TLR1 expression in TLR1 602S/S monocytes or NK cells. Previous report used 
flow cytometry- staining and confocal microscopy to detect the reduced surface 
expression of TLR1 variant. The discrepancy of my observation and their results might 
be partly due to the usage of different monoclonal antibodies and isotype controls for 
flow-cytometric detection of TLR1. Careful microscopic examinations on TLR1 
expressions of NK cells, T cells, and monocytes are needed to draw further 
conclusions.  
 
5.6 Association of TLR1 I602S and risk of gastric cancer 
Since lipopeptide of H. pylori, an essential etiology for gastric cancer, can be recognized 
by the TLR2/1 complex [36], we investigated the frequencies of functional SNPs of 
TLR1 and TLR2 in patients with gastric adenocarcinoma. TLR1 I602S was found to be 
associated with susceptibility to gastric cancer, while TLR2 R753Q was not involved. 
Remarkably, we observed that the TLR1 602S/S homozygous allele carriers had 
significantly higher risk of gastric cancer than people with 602I/I and 602I/S genotypes. 
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As described in the previous section, TLR1 602S/S impairs the TLR2/1-stimulated IFN-γ 
responses in NK cells and CD8+T cells, thus might lead to inadequate H. pylori 
elimination. In addition, IFN-γ together with cytotoxic activities of NK-and CD8+T cells 
are important for tumor surveillance [129]. Expression of IFN-inducible genes in PBMCs 
has been compared between healthy controls and patients suffering from different 
cancers, including gastric adenocarcinoma, in which cancer patients showed a 
significantly reduced response upon stimulation with IFN-γ [130]. The authors 
postulated that impaired IFN-γ signaling contributes to an early, persistent and global 
mechanism of immune dysfunction in cancer patients. Our finding that TLR1 602S 
homozygous individuals who showed lowered TLR2/1-induced IFN-γ response had 
increased risk for gastric cancer is in line with their results. 
Furthermore, we wanted to study the association of TLR1 602S SNP with H. pylori-
related gastric cancer pathogenesis. However, the H. pylori status of gastric cancer 
patients in this retrospective study was not retrievable. Yet, it is well-established that H. 
pylori is a strong risk factor for non-cardia gastric cancer, but not for cardia gastric 
cancer. Hence, we examined the frequencies of TLR1 602S/S genotype in patients with 
cardia- and non-cardia gastric cancers. The proportion of TLR1 602S homozygous 
individuals was found to be similar between patients with cardia- and non-cardia gastric 
adenocarcinomas, which indirectly excluded the association of the TLR-1 SNP with H. 
pylori infection. Therefore, the TLR1 I602S genetic polymorphism is less likely to play a 
role in the pathogenicity of H. pylori, but might be important in affecting the efficacy of 
the anti-tumor immune response. 
 
5.7 Association of TLR1 I602S and gastric cancer metastasis 
In addition to the increased susceptibility to gastric cancer, we found that the TLR-1 
I602S SNP is also involved in metastasis development. The variant allele carriers were 
at increased risk to have distant metastasis at the time of diagnosis. Unexpectedly, this 
correlation was observed not only in the homozygous- but also in the heterozygous- 
TLR1 I602S carriers, who did not exhibit an increased susceptibility for primary gastric 
cancer.  
It is possible that although the TLR1 602I/S individuals showed comparable IFN-γ and 
TNF-α production to wild type after in vitro Pam3Cys stimulation, they might have 
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reduced immune responses within the in vivo tumor-microenvironment. Once cancer is 
established and has been rapidly proliferated, endogenous molecules released from 
damaged tissue or necrotic tumor cells could also act as ligands for TLR2 and TLR4 
[131]. It has been reported that high-mobility-group box 1 (HMGB1), an alarmin protein 
released from dying tumor cells, could mount effective anti-Glioblastoma multiforme (an 
aggressive primary brain tumor) immune response via TLR2 activation [37].  These anti-
tumor responses included infiltration of myeloid DCs and clonal expansion of anti-tumor 
T cells. Therefore, the TLR1 I602S heterozygous subjects might already show some 
degree of impaired TLR2/1 responses in yet unknown aspects in response to 
endogenous gastric cancer-associated TLR2/1 ligands. 
 
5.8 Conclusion 
TLRs are differentially expressed on PBMC subsets. With our multi-color flow cytometric 
assay, we were able to detect potential impairment of TLR function in each cell type 
simultaneously. Due to its indispensible roles in herpes virus infections and cancer 
immunology, we focused specifically on TLR responses of NK cells. A large variation of 
TLR responses was observed in different individuals. The heterogeneous TLR-triggered 
IFN-γ responses in NK cells could result in differential susceptibility to HSV-1 diseases 
or cancer. 
In the second part of our study, we have observed both quantitative and qualitative 
defects in NK cells of people with recurrent HL. The poly(I:C)-induced IFN-γ responses 
were highest in NK cells derived from HSV-1-seronegative donors, followed by 
responses of asymptomatic HSV-1 carriers, and were lowest in people with 
symptomatic orolabial reactivations. The strong correlation of TLR3 responses of NK 
cells with the status of HSV-1 infection suggests that polymorphisms of molecules in the 
TLR3 signaling pathway (i.e. as described in [89,111]) might be essential factors for the 
increased susceptibility to HL. We have demonstrated that TLR3 L412F SNP could be 
one of these factors, which impairs the surface TLR3 expression and poly(I:C)-mediated 
IFN-γ responses of NK cells. Reduced IFN-γ production to R-848 was observed in the 
CD56bright NK cell sub-population of HL subjects, which could be restored by soluble 
factors secreted by monocytes or DCs, such as IL-15. Therefore, polymorphisms in 
TLR7/8 or IL-15 might play a role in susceptibility to HSV-1 reactivations as well. 
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In the third part of our study, we found that the TLR1 602S homozygous allele carriers 
showed not only decreased TNF-α responses to Pam3Cys in monocytes, but also 
significantly reduced IFN-γ responses in their NK cells and CD8+T cells. In a limited 
number of patients with recurrent HL, we did not observe a higher frequency of TLR1 
I602S SNP. However, associations of TLR1 I602S polymorphism with risks for gastric 
cancer and metastasis were detected.  
Our results suggest that genetic polymorphisms of TLRs can impair TLR function of NK 
cells, which contribute to the increased susceptibility to HL and gastric cancer. Further 
research on the means of boosting TLR3 responses of NK cells might provide a novel 
clinical therapy for patients with symptomatic HSV-1 reactivations. Moreover, studies on 
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